
<html lang="en"     class="pb-page"  data-request-id="d1a13aff-7a5d-4eaf-a2f3-ffc3a266eea7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2008.51.issue-23;article:article:10.1021/jm800523u"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Selectivity and Mechanism of Action of a Growth Factor Receptor-Bound Protein 2 Src Homology 2 Domain Binding Antagonist" /></meta><meta name="dc.Creator" content="Alessio  Giubellino" /></meta><meta name="dc.Creator" content="Zhen-Dan  Shi" /></meta><meta name="dc.Creator" content="Lisa M. Miller  Jenkins" /></meta><meta name="dc.Creator" content="Karen M.  Worthy" /></meta><meta name="dc.Creator" content="Lakshman K.  Bindu" /></meta><meta name="dc.Creator" content="Gagani  Athauda" /></meta><meta name="dc.Creator" content="Benedetta  Peruzzi" /></meta><meta name="dc.Creator" content="Robert J.  Fisher" /></meta><meta name="dc.Creator" content="Ettore  Appella" /></meta><meta name="dc.Creator" content="Terrence R.  Burke, Jr." /></meta><meta name="dc.Creator" content="Donald P.  Bottaro" /></meta><meta name="dc.Description" content="We have shown previously that a potent synthetic antagonist of growth factor receptor-bound protein 2 (Grb2) Src homology 2 (SH2) domain binding (1) blocks growth factor stimulated motility, invasi..." /></meta><meta name="Description" content="We have shown previously that a potent synthetic antagonist of growth factor receptor-bound protein 2 (Grb2) Src homology 2 (SH2) domain binding (1) blocks growth factor stimulated motility, invasi..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 7, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm800523u" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm800523u" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm800523u" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm800523u" /></link>
        
    
    

<title>Selectivity and Mechanism of Action of a Growth Factor Receptor-Bound Protein 2 Src Homology 2 Domain Binding Antagonist | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm800523u" /></meta><meta property="og:title" content="Selectivity and Mechanism of Action of a Growth Factor Receptor-Bound Protein 2 Src Homology 2 Domain Binding Antagonist" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0001.jpeg" /></meta><meta property="og:description" content=" We have shown previously that a potent synthetic antagonist of growth factor receptor-bound protein 2 (Grb2) Src homology 2 (SH2) domain binding (1) blocks growth factor stimulated motility, invasion, and angiogenesis in cultured cell models, as well as tumor metastasis in animals. To characterize the selectivity of 1 for the SH2 domain of Grb2 over other proteins containing similar structural binding motifs, we synthesized a biotinylated derivative (3) that retained high affinity Grb2 SH2 domain binding and potent biological activity. To investigate the selectivity of 1 and 3 for Grb2, the biotinylated antagonist 3 was used to immobilize target proteins from cell extracts for subsequent identification by mass spectrometry. Non-specific binding was identified in parallel using a biotinylated analogue that lacked a single critical binding determinant. The mechanism of action of the antagonist was further characterized by immunoprecipitation, immunoblotting, and light microscopy. This approach to defining protein binding antagonist selectivity and molecular basis of action should be widely applicable in drug development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm800523u"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm800523u">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm800523u&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm800523u&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm800523u&amp;href=/doi/10.1021/jm800523u" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 7459-7468</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm800527x" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm801005m" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Selectivity and Mechanism of Action of a Growth Factor Receptor-Bound Protein 2 Src Homology 2 Domain Binding Antagonist</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alessio++Giubellino">Alessio Giubellino</a></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhen-Dan++Shi">Zhen-Dan Shi</a></span><span class="author-xref-symbol "><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lisa+M.+Miller++Jenkins">Lisa M. Miller Jenkins</a></span><span class="author-xref-symbol "><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karen+M.++Worthy">Karen M. Worthy</a></span><span class="author-xref-symbol "><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lakshman+K.++Bindu">Lakshman K. Bindu</a></span><span class="author-xref-symbol "><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gagani++Athauda">Gagani Athauda</a></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benedetta++Peruzzi">Benedetta Peruzzi</a></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+J.++Fisher">Robert J. Fisher</a></span><span class="author-xref-symbol "><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ettore++Appella">Ettore Appella</a></span><span class="author-xref-symbol "><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Terrence+R.++Burke%2C++Jr.">Terrence R. Burke, Jr.</a></span><span class="author-xref-symbol "><sup>â¡</sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald+P.++Bottaro">Donald P. Bottaro</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Urologic Oncology Branch and Laboratory of Cell Biology, National Cancer Institute, Bethesda, Maryland 20892, Laboratory of Medicinal Chemistry, National Cancer Institute at Frederick, Frederick, Maryland 21702 and Protein Chemistry Laboratory-SAIC, Frederick, Maryland 21702</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Address: Urologic Oncology Branch, CCR, NCI, Buildingg 10 CRC 1, West Room 3961, 10 Center Drivem MSC 1107, Bethesda, MD 20892-1107. Telephone: (301) 402-6499. Fax: (301) 402-0922. E-mail: <a href="/cdn-cgi/l/email-protection#85e1e7eaf1f1e4f7eac5ede0e9ecfdabebecedabe2eaf3"><span class="__cf_email__" data-cfemail="5337313c272732213c133b363f3a2b7d3d3a3b7d343c25">[emailÂ protected]</span></a></div><div class="corresp-fn" id="afn1">â Urologic Oncology Branch, National Cancer Institute.</div><div class="corresp-fn" id="afn2">â¡Laboratory of Medicinal Chemistry, National Cancer Institute at Frederick.</div><div class="corresp-fn" id="afn3">Â§Laboratory of Cell Biology, National Cancer Institute.</div><div class="corresp-fn" id="afn4">â¥Protein Chemistry Laboratory, SAIC-Frederick, Inc.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm800523u&amp;href=/doi/10.1021%2Fjm800523u" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 7459â7468</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 7, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 May 2008</li><li><span class="item_label"><b>Published</b> online</span>7 November 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 December 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm800523u" title="DOI URL">https://doi.org/10.1021/jm800523u</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7459%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAlessio%2BGiubellino%252C%2BZhen-Dan%2BShi%252C%2BLisa%2BM.%2BMiller%2BJenkins%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D23%26contentID%3Djm800523u%26title%3DSelectivity%2Band%2BMechanism%2Bof%2BAction%2Bof%2Ba%2BGrowth%2BFactor%2BReceptor-Bound%2BProtein%2B2%2BSrc%2BHomology%2B2%2BDomain%2BBinding%2BAntagonist%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7468%26publicationDate%3DDecember%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm800523u"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1119</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">8</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm800523u" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Selectivity and Mechanism of Action of a Growth Factor Receptor-Bound Protein 2 Src Homology 2 Domain Binding Antagonist&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Alessio&quot;,&quot;last_name&quot;:&quot;Giubellino&quot;},{&quot;first_name&quot;:&quot;Zhen-Dan&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;M. Miller Jenkins&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;M. Worthy&quot;},{&quot;first_name&quot;:&quot;Lakshman&quot;,&quot;last_name&quot;:&quot;K. Bindu&quot;},{&quot;first_name&quot;:&quot;Gagani&quot;,&quot;last_name&quot;:&quot;Athauda&quot;},{&quot;first_name&quot;:&quot;Benedetta&quot;,&quot;last_name&quot;:&quot;Peruzzi&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;J. Fisher&quot;},{&quot;first_name&quot;:&quot;Ettore&quot;,&quot;last_name&quot;:&quot;Appella&quot;},{&quot;first_name&quot;:&quot;Terrence&quot;,&quot;last_name&quot;:&quot;R. Burke&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;P. Bottaro&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;7459-7468&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm800523u&quot;},&quot;abstract&quot;:&quot;We have shown previously that a potent synthetic antagonist of growth factor receptor-bound protein 2 (Grb2) Src homology 2 (SH2) domain binding (1) blocks growth factor stimulated motility, invasion, and angiogenesis in cultured cell models, as well as tumor metastasis in animals. To characterize the selectivity of 1 for the SH2 domain of Grb2 over other proteins containing similar structural binding motifs, we synthesized a biotinylated derivative (3) that retained high affinity Grb2 SH2 domain binding and potent biological activity. To investigate the selectivity of 1 and 3 for Grb2, the biotinylated antagonist 3 was used to immobilize target proteins from cell extracts for subsequent identification by mass spectrometry. Non-specific binding was identified in parallel using a biotinylated analogue that lacked a single critical binding determinant. The mechanism of action of the antagonist was further characterized by immunoprecipitation, immunoblotting, and light microscopy. This approach to defining prote&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800523u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800523u" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800523u&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800523u" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800523u&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800523u" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm800523u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800523u&amp;href=/doi/10.1021/jm800523u" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm800523u" /></input><a href="/doi/pdf/10.1021/jm800523u" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (901 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm800523u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm800523u%26sid%3Dliteratum%253Aachs%26pmid%3D18989951%26genre%3Darticle%26aulast%3DGiubellino%26date%3D2008%26atitle%3DSelectivity%2Band%2BMechanism%2Bof%2BAction%2Bof%2Ba%2BGrowth%2BFactor%2BReceptor-Bound%2BProtein%2B2%2BSrc%2BHomology%2B2%2BDomain%2BBinding%2BAntagonist%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D23%26spage%3D7459%26epage%3D7468%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/medium/jm-2008-00523u_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800523u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We have shown previously that a potent synthetic antagonist of growth factor receptor-bound protein 2 (Grb2) Src homology 2 (SH2) domain binding (<b>1</b>) blocks growth factor stimulated motility, invasion, and angiogenesis in cultured cell models, as well as tumor metastasis in animals. To characterize the selectivity of <b>1</b> for the SH2 domain of Grb2 over other proteins containing similar structural binding motifs, we synthesized a biotinylated derivative (<b>3</b>) that retained high affinity Grb2 SH2 domain binding and potent biological activity. To investigate the selectivity of <b>1</b> and <b>3</b> for Grb2, the biotinylated antagonist <b>3</b> was used to immobilize target proteins from cell extracts for subsequent identification by mass spectrometry. Non-specific binding was identified in parallel using a biotinylated analogue that lacked a single critical binding determinant. The mechanism of action of the antagonist was further characterized by immunoprecipitation, immunoblotting, and light microscopy. This approach to defining protein binding antagonist selectivity and molecular basis of action should be widely applicable in drug development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08874" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08874" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Antagonists of proteinâprotein interactions have significant therapeutic potential in a broad range of indications, including cancer. However, defining target selectivity and defining the molecular basis of therapeutic effects are important challenges to their development and use. For this class of drug in particular, systematic exploration of these subjects at the earliest stages of development can profoundly improve prediction, measurement and avoidance of drug toxicity, identification of appropriate patient populations, and drug efficacy assessment. In the long term, systematically defining selectivity and mechanism of action may also accelerate target validation and facilitate the design of improved therapeutic and diagnostic agents. The modification of investigational compounds with chemical tags such as biotin is among the most direct strategies yet devised to address these questions, and this approach was utilized in our present investigation.</div><div class="NLM_p">Ligand binding, receptor overexpression, and/or oncogenic mutations can induce receptor tyrosine kinase (RTK<a class="ref internalNav" href="#fn2" aria-label="a">a</a>) <div class="NLM_fn" id="fn2">a<p class="last">Abbreviations: Grb2, growth factor receptor-bound protein 2; SH2, Src homology 2; RTK, receptor tyrosine kinase; EGFR, epidermal growth factor receptor; HGF, hepatocyte growth factor; PDGFR, platelet-derived growth factor receptor; FAK, focal adhesion kinase; Bcr, breakpoint cluster region; Abl, Abelson murine leukemia viral oncogene; SH3, Src homology 3; Ras, rat sarcoma virus oncogene; Erk, extracellular signal-regulated kinase; PAK1, p21-activating kinase; Arp2/3, actin related protein 2/3; WASp, WiskottâAldrich syndrome protein; EMT, epithelial-mesenchymal transition; SPR, surface plasmon resonance; SA, streptavidin; Nck, noncatalytic region of tyrosine kinase adaptor protein; Gab1, growth factor receptor protein 2 associated protein 1; SOS1, son of sevenless homologue 1; ESI-MS/MS, electrospray ionization tandem mass spectrometry; Rac, rat sarcoma virus oncogene related C3 botulinum toxin substrate; CDC42, cell division cycle 42; cAMP, cyclic adenosine monophosphate; CREB, cyclic adenosine monophosphate response element binding; MDCK, MadinâDarby canine kidney cell; DAPI, 4â²,6-diamidino-2-phenylindole; DPPP, 1,3-bis(diphenylphosphine)propane; EDC, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide; HOBt, 1-hydroxybenzotriazole; DMAP, 4-dimethylaminopyridine; DMF, dimethylformamide; THF, tetrahydrofuran; DIPCDI, diisopropylcarbodiimide; TFA-TES, trifluoroacetic acidâ<i>N</i>-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid.</p></div> activation and autophosphorylation of specific tyrosine residues within RTK intracellular domains. A prominent consequence of tyrosine phosphorylation is the formation of docking sites for proteins containing Src homology 2 (SH2) domains.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> One of the best characterized proteins of this class is growth factor receptor bound protein 2 (Grb2), an adapter that acts as a critical downstream intermediary in several oncogenic signaling pathways. Originally isolated through screening for epidermal growth factor receptor (EGFR) interacting proteins,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Grb2 associates with several signaling and regulatory proteins. Through its SH2 domain, which is a conserved sequence of approximately 100 amino acids, Grb2 can interact directly with RTKs (e.g., hepatocyte growth factor (HGF) receptor, platelet-derived growth factor receptor) and non-receptor tyrosine kinases (e.g., focal adhesion kinase (FAK) and Bcr/Abl) by preferential binding to phosphopeptide motifs of the form pYXNX, where pY represent phosphotyrosine, N is asparagine, and X is any residue.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The amino- and carboxyl-terminal Src homology 3 (SH3) domains of Grb2, which have a conserved sequence of around 50 amino acids, bind proline-rich regions within additional interacting proteins. Through these two SH3 domains, Grb2 links activated RTKs with several key intracellular regulatory networks, including the Ras/Erk pathway controlling cell cycle progression, and the p21-activating kinase (PAK1) and Arp2/3/WASp pathways regulating the actin filament system, cell shape change, and motility.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Grb2 is also a key intermediate of integrin signaling through its interaction with activated FAK at pY925, which resides within a canonical recognition motif (pYXNX) for the Grb2 SH2 domain.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Grb2-FAK binding triggers a signaling sequence involved in angiogenesis and epithelial-mesenchymal transition (EMT), both of which are important contributors to tumor progression.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a></div><div class="NLM_p">The critical roles served by Grb2 in cell motility and angiogenesis make it a logical therapeutic target for pathological processes leading to the spread of solid tumors through local invasion and metastasis.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Potent, synthetic, low molecular weight antagonists of Grb2 SH2 domain binding have been developed that block RTK-Grb2 interaction and growth factor-stimulated motility and matrix invasion by several tumor cell lines.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> We have previously reported that the Grb2 SH2 domain binding antagonist <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) can inhibit cell motility,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> angiogenesis,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and tumor metastasis <i>in vivo</i>.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> To better understand the SH2 domain selectivity and mechanism of action of this class of compounds, we designed and synthesized biotinylated derivatives of two biologically active structures and established that high affinity Grb2 binding was maintained. The synthesis and binding evaluation of a macrocyclic Grb2 SH2 domain binding antagonist that bears the biotin functionality at a carboxyl-terminal position were described in a prior report.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In the current work, we present the synthesis of a hydroxylated variant of <b>1</b> (<b>2</b>) as well as an open-chain biotinylated version of <b>1</b> (<b>3</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). We use <b>2</b> and <b>3</b> as tools to explore ligand selectivity through immobilization by streptavidin-coated beads and subsequent mass spectrometry analysis. We further evaluated the biological mechanism of action of the compound in intact cells and report herein the inhibition of lamellipodia formation by <b>1</b> as a molecular basis for its antimotility activity.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/medium/jm-2008-00523u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of Grb2-SH2 domain binding antagonists and analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800523u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65418" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65418" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Syntheses</h3><div class="NLM_p">Syntheses of <b>2</b> and the biotinylated conjugates <b>3</b> and <b>4</b> were similar to the previously reported procedures<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and differed mainly in the preparation of segment <b>9</b>. Starting from 1,5-dihydroxylnaphthalene <b>5</b>, the monohydroxyl group was protected as the triflate using <i>N</i>-phenyltrifluoromethanesulfonimide and 2,4,6-collidine (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Subsequent Heck reaction proved troublesome because the CâO bond is more stable compared to the Câhalide bond and requires higher cleavage energy. Thus, no reaction was observed under the commonly used Heck reaction conditions of palladium(II) acetate and tri-<i>O</i>-tolylphosphine. However, with the more active phosphine ligand 1,3-bis(diphenylphosphine)propane (DPPP),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> two coupling products were obtained as the expected adduct <b>7</b> and its reductive product <b>8</b> in combined 81% yield. After reduction of both adducts with lithium aluminum hydride, the primary amine <b>9</b> was obtained in 54% yield. By use of standard coupling procedures, asparagine and 1-aminocyclohexenecarboxylic acid were added to yield the dipeptide <b>10</b>.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/medium/jm-2008-00523u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0008.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Upper Segment <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800523u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions and yields: (a) Tf<sub>2</sub>NPh, 2,4,6-collidine, DMAP, DMFâCH<sub>2</sub>Cl<sub>2</sub>, reflux, 12 h, 47%; (b) Pd(OAc)<sub>2</sub>, DPPP, Et<sub>3</sub>N, reflux, 14 h, 81%; (c) LiAlH<sub>4</sub>, THF, room temp, overnight, 54%; (d) (i) Boc-Asn-OH, DIPCDI, HOBt, DMF, room temp, 12 h, 87%; (ii) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temp, 1 h, 79%; (iii) Fmoc-1-aminocyclohexenecarboxylic acid, EDC, HOBt, DMF, room temp, 12 h, 79%; (iv) piperidine, CH3CN, room temp, 2 h, 86%.</p></p></figure><div class="NLM_p">Coupling of the upper peptide segment <b>10</b> and the bottom residues <b>11a</b>,<b>b</b> (<b>11a</b> was prepared as previously described;<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a><b>11b</b> was available from Novobiochem Corp.) was performed in the presence of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) and hydroxybenzotriazole (HOBt) to give <b>12a</b> and <b>12b</b> in 79% yield and 74% yield, respectively (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Piperidine-mediated cleavage of <i>N-</i>Fmoc followed by protection of the resulting free amino group with <i>tert-</i>butyloxalyl chloride produced <b>13a</b> and <b>13b</b> in 43% yield and 80% yield, respectively. Of note, the 5-phenol remained unaffected by the coupling reaction conditions and was subsequently coupled to the biotinylated linker in the next step. Global deprotection of <i>tert-</i>butyl ester of <b>13a</b> gave final product <b>2</b>. Coupling of <b>13a</b> and <b>13b</b> to the biotinylated linker was performed in the presence of EDC and 4-dimethylaminopyridine (DMAP) to provide the desired products <b>14a</b> and <b>14b</b> in 78% and 42% yield, respectively. These were converted to the corresponding free acids <b>3</b> and <b>4</b> after cleavage of the <i>tert-</i>butyl esters.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/medium/jm-2008-00523u_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0009.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Inhibitor <b>2</b> and Biotinylated Ligands <b>3</b> and <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800523u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions, and yields: (a) EDC, HOBt, DMF, room temp, 12 h (79% for <b>12a</b>, 74% for <b>12b</b>); (b) (i) piperidine, CH3CN, room temp, 2 h; (ii) <i>tert</i>-butyloxalyl chloride, <sup><i>i</i></sup>Pr2NEt, DMF, room temp, 12 h (two steps, 43% for <b>13a</b>; 80% for <b>13b</b>); (c) TFAâTESâH<sub>2</sub>O, room temp, 1 h, 42%; (d) EDC, DMAP, DMF, room temp, 12 h (78% for <b>14a</b>, 42% for <b>14b</b>); (e) TFAâHS(CH<sub>2</sub>)<sub>2</sub>SHâH<sub>2</sub>O, room temp, 1 h (41% for <b>3</b>, 56% for <b>4</b>).</p></p></figure><div class="NLM_p last">To characterize the selectivity of the Grb2 SH2 domain antagonist compound <b>1</b> for the SH2 domain of Grb2 over other proteins containing similar motifs, analogues <b>2</b> and <b>3</b> were prepared, the latter bearing biotin functionality at a carboxyl-terminal position. The compound was biotinylated by attaching the biotin to the naphthyl ring as described above. Biotin is commonly attached to biologically active molecules by means of a 6-aminocaproic acid ester spacer without unduly affecting their biological activities; the spacer minimizes potential steric interactions between avidin and the Grb2 SH2 domainâligand complex. A biotinylated variant of <b>1</b> that had very poor Grb2 SH2 domain binding affinity (<b>4</b>) was prepared in parallel and used as a negative control throughout the course of these studies. Analogue <b>4</b> is similar to <b>3</b>, except that <b>4</b> does not contain a phosphoryl mimetic at the 4-position of the tyrosyl mimetic aryl ring, which is a critical requirement for high affinity SH2 domain binding.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Binding Affinities of Grb2 SH2 Domain Antagonists</h3><div class="NLM_p">The Grb2 SH2 domain binding affinities of <b>2</b> and its biotin-containing counterpart <b>3</b> were determined by surface plasmon resonance (SPR). Binding constants for SH2 domain-small molecule interactions typically have been determined indirectly by measuring the ability of a small molecule to compete with sensor-bound reference pTyr-containing peptide for the binding of SH2 domain-containing protein in the mobile phase. Significant improvements in the sensitivity and operation of SPR instrumentation now permit accurate direct binding measurements of small compounds such as <b>2</b> and <b>3</b> to SH2 domain proteins immobilized on the sensor chip. Data were analyzed to a one-site binding model using Scrubber software (<a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, compound <b>2</b> bound to amine-coupled Grb2 SH2 domain with a steady state affinity of 132 nM while compound <b>3</b> displayed 3-fold lower binding affinity (405 nM), indicating only modest perturbation of antagonist-SH2 domain interaction by the added biotin functionality.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Grb2 and Shc SH2 Domain Steady State Binding Affinities Determined by Surface Plasmon Resonance Spectrometry (Biacore)</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">SH2 domain</th><th align="center" valign="middle">coupling<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></th><th align="center" valign="middle" char=".">affinity (nM)</th><th align="center" valign="middle" char=".">ratio</th></tr></thead><tbody><tr valign="top"><td align="left"><b>2</b></td><td align="left">Grb2</td><td align="left">amine</td><td align="char" char=".">132</td><td align="char" char=".">1</td></tr><tr valign="top"><td align="left"><b>3</b></td><td align="left">Grb2</td><td align="left">amine</td><td align="char" char=".">405</td><td align="char" char=".">3</td></tr><tr valign="top"><td align="left"><b>1</b></td><td align="left">biotin-Grb2</td><td align="left">SA</td><td align="char" char=".">370</td><td align="char" char=".">1</td></tr><tr valign="top"><td align="left"><b>1</b></td><td align="left">biotin-Shc</td><td align="left">SA</td><td align="char" char=".">24000</td><td align="char" char=".">65</td></tr><tr valign="top"><td align="left"><b>2</b></td><td align="left">biotin-Grb2</td><td align="left">SA</td><td align="char" char=".">93</td><td align="char" char=".">1</td></tr><tr valign="top"><td align="left"><b>2</b></td><td align="left">biotin-Shc</td><td align="left">SA</td><td align="char" char=".">9400</td><td align="char" char=".">101</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Coupling to the chip surface via amine linkage or streptavidin (SA) capture of biotinylated recombinant proteins.</p></div></div></div><div class="NLM_p last">As part of our target selectivity assessment of these SH2 antagonists, we compared their binding to the SH2 domains of Grb2 and Shc by SPR. The Shc SH2 domain recognizes the same general sequence motif as all known SH2 domains (pYXXX), but unlike Grb2 does not require asparagine (N) at the pY + 2 position (pYXNX). While prior studies indicate that compounds such as <b>3</b> are unlikely to bind Src-like SH2 domains with high affinity, the potential for Shc SH2 domain binding is not easily predicted because its three-dimensional structure differs significantly from those of the Src-like kinases and Grb2.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> For these SPR studies, the Grb2 and Shc SH2 domains were recombinantly engineered to contain a biotin tag at the encoded 5â² end.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Immobilization of these constructs on sensor chips coated with streptavidin (SA) provides uniform orientation on the chip surface and thereby less variability in ligand binding. The binding affinity of <b>2</b> for SA-immobilized biotin-Grb2 was in good agreement with the value obtained when Grb2 was immobilized by amine coupling (93 vs 132 nM, respectively, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Of note, compound <b>2</b> displayed 100-fold lower binding affinity for biotin-Shc than for biotin-Grb2 (93 vs 9400 nM, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), indicating a high degree of Grb2 selectivity. Consistent with its overall similarity to compound <b>2</b>, compound <b>1</b> also displayed dramatically lower binding affinity for the SH2 domain of Shc relative to that of Grb2 (370 vs 24â000 nM, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Biotinylated <b>3</b> Retains Anti-motility Activity and Is Highly Selective for Grb2</h3><div class="NLM_p">We have shown previously that the SH2 domain binding antagonist <b>1</b> blocks cell motility in a dose dependent fashion.<a onclick="showRef(event, 'ref11 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref13">(11, 13)</a> To confirm that biotin-containing <b>3</b> retains the biological activity of the parent compound <b>1</b> in intact cells, we performed cell migration studies using modified Boyden chambers in the presence or absence of the protein motility factor HGF (50 ng/mL). As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A, <b>3</b> has anti-migratory activity comparable to that of the parent compound <b>1</b>, resulting in significant and potent inhibition of migration by the prostate tumor-derived cell line PC3M. Detailed dose-response analysis of inhibition of migration by <b>3</b> yielded an estimated IC<sub>50</sub> value of 14 nM (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B; <i>R</i><sup>2</sup> = 0.9, <i>P</i> < 0.01). No inhibition of cell migration was observed in response to treatment with the negative control analogue <b>4</b> at any concentration tested (data not shown).</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/medium/jm-2008-00523u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Inhibition of cell migration by <b>1</b> and <b>3</b>. (A) Inhibition of HGF-stimulated (50 ng/mL, white bar) or unstimulated (black bar) PC3M cell migration by <b>1</b> and <b>3</b>. Values represent mean number of migrated cells per 10Ã microscopic field, expressed as percent maximum, Â±standard deviation. (B) Dose-response analysis of inhibition of PC3M cell migration by <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800523u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In order to verify that <b>3</b> could efficiently capture Grb2 from detergent extracts of cultured cells, SA-coated beads were treated with biotin-containing <b>3</b> or <b>4</b> under conditions designed to saturate available SA sites. The compound-conjugated SA beads were then incubated with non-ionic detergent extracts prepared from cultured tumor cells and washed with buffers of increasing ionic strength (150â500 mM NaCl) to remove loosely bound proteins (monitored by silver staining, data not shown). The washes were analyzed for retention of Grb2 by SDSâPAGE and immunoblotting (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). Grb2 was clearly retained on compound <b>3</b>-conjugated SA beads, but in contrast, ligand <b>4</b> did not capture Grb2 under any conditions tested. We also confirmed the ability of <b>3</b> to capture proteins that are known to bind to the SH3 domains of Grb2; SDSâPAGE and immunoblot analysis of proteins captured by SA-bound <b>3</b> revealed the presence of Nck1, Nck2, Gab1, and Sos1 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/medium/jm-2008-00523u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Protein capture by <b>3</b> and <b>4</b>. (A) SDSâPAGE and anti-Grb2 immunoblot analysis of lysates prepared from the human leiomyosarcoma cell line SK-LMS-1. Following target protein capture using <b>3</b> (left) or <b>4</b> (right), SA-coated beads were washed with buffer containing NaCl at the concentrations (M) indicated above each lane. (B) SDSâPAGE and immunoblot analysis of SK LMS-1 lysates (left lane) for known Grb2-associated proteins (top to bottom) Nck1, Nck2, Gab1, and Sos1 captured using <b>4</b> (middle lane) or <b>3</b> (right lane).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800523u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Proteins captured from cell extracts using compound <b>3</b>-conjugated SA beads under conditions where Grb2 binding was detected by immunoblotting were subjected to exhaustive trypsin digestion; the resulting peptides were then separated chromatographically by HPLC and analyzed by tandem mass spectrometry (ESI-MS/MS) on a linear ion trap mass spectrometer. Representative ESI-MS/MS spectra of two [M + 2H]<sup>2+</sup> tryptic peptides from Grb2 (NH<sub>2</sub>-GACHGQTGMFPR-COOH and NH<sub>2</sub>-ATADDELSFK-COOH; NCBI sequence accession <a href="https://NM_203506.2" class="ext-link">NM_203506.2</a>) that were captured by compound <b>3</b>-conjugated SA beads, but not by compound <b>4</b>-conjugated beads, and which represent 10.1% sequence coverage, are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. The b ion series is shown in red and the y ion series in blue. Statistical analysis using the Sequest algorithm yielded peptide correlation (Xcorr) scores of 3.707 (<i>p</i> = 1.9 Ã 10<sup>â9</sup>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A) and 2.98 (<i>p</i> = 1.4 Ã 10<sup>â5</sup>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B) for the two peptides. The difference in correlation between the top two peptide matches (ÎCn) were 0.44 and 0.28 for the spectra shown in parts A and B of Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, respectively; together with the peptide correlation scores, these values confirm robust protein identification. Importantly, Grb2 was the only SH2-domain containing protein detected by ESI-MS/MS among the proteins captured from cell lysates by <b>3</b> or the negative control <b>4</b>. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, five other proteins were captured differentially by <b>3</b> with Grb2; further research will be needed to determine whether their capture was mediated by Grb2 or by direct interaction with <b>3</b>. Overall, these results confirm and extend our prior findings that <b>1</b> and closely related structures selectively block the Grb2 SH2 domain and not structurally distinct SH2 domains such as those present in Shc or phosphatidylinositol-3 kinase.<a onclick="showRef(event, 'ref11 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref13">(11, 13)</a></div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/medium/jm-2008-00523u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative MS/MS spectra of two [M + 2H]<sup>2+</sup> tryptic peptides from Grb2, which represent 10.1% sequence coverage, captured by <b>3</b>-conjugated beads but not <b>4</b>-conjugated beads. The b ion series is shown in red and the y ion series in blue. Sequest statistics are as follows: (A) Xcorr score = 3.707, ÎCn = 0.44, and <i>p</i> = 1.9 Ã 10<sup>â9</sup>; (B) Xcorr score = 2.98, ÎCn = 0.28, and <i>p</i> = 1.4 Ã 10<sup>â5</sup>, where Xcorr is the peptide correlation score and ÎCn is the difference in correlation between the top two peptide matches.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800523u&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Peptides Identified by Mass Spectrometry Analysis of Samples Captured from Cell Lysates by Streptavidin-Immobilized <b>3</b> but Not by Streptavidin-Immobilized <b>4</b><a class="ref internalNav" href="#tbl2-fn3" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">peptide sequences observed</th><th align="center" valign="middle">NCBI accession</th><th align="center" valign="middle">protein name</th><th align="center" valign="middle">probability</th><th align="center" valign="middle" char=".">Xcorr score</th></tr></thead><tbody><tr valign="top"><td align="left">K.LLDFGSLSNLQVTQPTVGMNFK.T</td><td align="left"><a href="https://4506693" class="ext-link">4506693</a></td><td align="left">ribosomal protein S17</td><td align="left">9.53 Ã 10<sup>â12</sup></td><td align="char" char=".">48.31</td></tr><tr valign="top"><td align="left">R.VCEEIAIIPSKK.L</td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">R.VIIEKYYTR.L</td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">K.IAGYVTHLMKR.I</td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">R.LGNDFHTNK.R</td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">K.IYVDDGLISLQVK.Q</td><td align="left"><a href="https://33286418" class="ext-link">33286418</a>, <a href="https://33286420" class="ext-link">33286420</a></td><td align="left">pyruvate kinase 3<a class="ref internalNav" href="#tbl2-fn1" aria-label="b">b</a></td><td align="left">1.10 Ã 10<sup>â6</sup></td><td align="char" char=".">40.24</td></tr><tr valign="top"><td align="left">R.NTGIICTIGPASR.S</td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">R.GDLGIEIPAEK.V</td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">R.VNFAMNVGK.A</td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">K.ATADDELSFK.R</td><td align="left"><a href="https://45359859" class="ext-link">45359859</a></td><td align="left">Grb2</td><td align="left">2.17 Ã 10<sup>â6</sup></td><td align="char" char=".">20.83</td></tr><tr valign="top"><td align="left">K.GACHGQTGMFPR.N</td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">K.AMGIMNSFVNDIFER.I</td><td align="left"><a href="https://4504257" class="ext-link">4504257</a>, <a href="https://4504271" class="ext-link">4504271</a></td><td align="left">histone H2B family<a class="ref internalNav" href="#tbl2-fn2" aria-label="c">c</a></td><td align="left">6.51 Ã 10<sup>â6</sup></td><td align="char" char=".">20.23</td></tr><tr valign="top"><td align="left">R.KESYSIYVYK.V</td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">K.VANVSLLALYK.G</td><td align="left"><a href="https://4506701" class="ext-link">4506701</a></td><td align="left">ribosomal protein S23</td><td align="left">2.12 Ã 10<sup>â7</sup></td><td align="char" char=".">20.2</td></tr><tr valign="top"><td align="left">K.AHLGTALK.A</td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="char" char=".">Â </td></tr><tr valign="top"><td align="left">K.SAEFLLHMLK.N</td><td align="left"><a href="https://4506617" class="ext-link">4506617</a></td><td align="left">ribosomal protein L17</td><td align="left">5.16 Ã 10<sup>â5</sup></td><td align="char" char=".">10.16</td></tr><tr valign="top"><td align="left">K.GLDVDSLVIEHIQVNK.A</td><td align="left">Â </td><td align="left">Â </td><td align="left">Â </td><td align="char" char=".">Â </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn3"><div class="footnote" id="tbl2-fn3"><sup>a</sup><p class="last">Only those proteins for which two or more unique peptides were observed are shown. Probability is the <i>p</i>-value for the identification of the protein context of the peptide. Xcorr score is the calculated correlation value for the protein based on the combined Xcorr values of the peptides, obtained using the Sequest algorithm.</p></div><div class="footnote" id="tbl2-fn1"><sup>b</sup><p class="last">Unable to distinguish isoforms.</p></div><div class="footnote" id="tbl2-fn2"><sup>c</sup><p class="last">Unable to distinguish H2B family members.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Molecular and Cellular Mechanism of Action of <b>1</b></h3><div class="NLM_p">Having established the selectivity of <b>1</b> for the SH2 domain of Grb2, we further investigated its molecular mechanism of action by determining its effect on the activation state and subcellular localization of oncogenically relevant downstream signaling proteins. We focused on proteins most likely to be involved in the activities blocked by <b>1</b>, namely, cell adhesion and motility. The p21-activated kinase 1 (PAK1) is an effector of Rac/Cdc42 GTPases that regulates cytoskeletal dynamics and is essential for cell migration. PAK1 binds directly to Grb2 SH3 domains, and its linkage to Grb2 is critical for PAK1 activation, autophosphorylation, and lamellipodia formation downstream of growth factor-stimulated RTKs.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> We theorized that disrupting the SH2-mediated link between Grb2 and initiators of motility signaling, such as activated RTKs and integrin receptors, might also block PAK1 activation and autophosphorylation without affecting the SH3 domain-mediated PAK1-Grb2 association. We investigated the effect of <b>1</b> on growth factor-stimulated PAK1 activation by treating intact PC3M cells with <b>1</b> (1 Î¼M) for 16 h (vs leaving them untreated), then stimulating the cells briefly with HGF and monitoring PAK1 activation by immunoblotting with a specific anti-phospho-PAK1 antibody (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A). Treatment with <b>1</b> had little effect on the steady state level of PAK1 autophosphorylation, which is not associated with cell shape change or motility (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A, left 2 lanes). In the absence of <b>1</b>, HGF stimulation results in an initial decrease and then increase in PAK1 autophosphorylation after 30â60 min, which is correlated with cell shape change and lamellipodia extension prior to increased motility (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A, middle lanes). This latter process of HGF-stimulated PAK1 activation, which is critical to motility, was completely inhibited by treatment with <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A, right lanes).</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/medium/jm-2008-00523u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>1</b> inhibits PAK1 activation and nuclear translocation. (A) PC3M cells were serum-deprived and treated with <b>1</b> (+, 1 Î¼M) or left untreated (â), as indicated, for 16 h, then left without further treatment (left lanes) or stimulated briefly with HGF (50 ng/mL, right lanes) for the times indicated. Cell lysates were analyzed by SDSâPAGE, and immunoblot analysis was done with anti-phospho-PAK1 antibody (upper panel) or anti-PAK1 antibody to control for protein loading (lower panel). (B) PC3M cells were treated with compound <b>1</b> for 16 h, and nuclear extracts were prepared using high-salt buffer. Samples were analyzed by SDSâPAGE, and immunoblot analysis was done with anti-PAK1 antibody (upper panel) or anti-CREB antibody (lower panel).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800523u&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Growth factor-stimulated activation of PAK1 has been associated with nuclear translocation, histone protein phosphorylation, and modulation of expression of several gene transcripts.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Increased nuclear PAK1 activity has been reported in human renal cell carcinoma cells<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and in estrogen receptor-positive breast cancer,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> where it was correlated with tamoxifen resistance. We found that treatment of intact cells with <b>1</b> decreased PAK1 nuclear translocation (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B, upper panel) relative to nuclear cAMP response element-binding (CREB) protein (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B, lower panel), which is not modulated by growth factor stimulation.</div><div class="NLM_p">Reorganization of the actin cytoskeleton is an early and critical step in lamellipodia formation prior to cell migration. We examined whether antagonism of Grb2 SH2 domain binding affected growth-factor stimulated actin reorganization and lamellipodia formation by staining cells with fluorescently labeled phalloidin, a toxin that interacts specifically with polymerized F-actin bundles. Lamellipodia formation is conveniently analyzed in monolayer cell cultures by directing their formation at an artificially created wound edge. To this end, confluent monolayers were scratched with a pipet tip, stimulated with HGF in the presence or absence of <b>1</b> for 6 h, then stained with fluorescently tagged phalloidin. Because lamellipodia formation is cell-type dependent, we examined this process in the prostate tumor-derived cell line PC3M and in the highly organized, normal epithelial cell line MDCK (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). HGF-stimulated PC3M cells displayed abundant pointed edges of advancing plasma membrane in the direction of cell migration (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, top left panel), while treatment with <b>1</b> markedly reduced phalloidin staining at the leading edge, indicative of a reduced actin bundle reorganization and membrane extension (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, bottom left panel). In contrast to PC3M cells, the actin cytoskeletal structure of MDCK cells is more uniformly organized (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, right panels). HGF stimulation produced the formation of well-structured advancing lamellipodia (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> top center and right panels). Treatment with <b>1</b> significantly reduced the area and distance that lamellipodia extended into the wound, consistent with inhibition of directional cell migration (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, bottom center and right panels).<a onclick="showRef(event, 'ref11 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref13">(11, 13)</a></div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/medium/jm-2008-00523u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>1</b> inhibits lamellipodia formation: Alexa 488-phalloidin (green) and DAPI staining (blue) of PC3M cells (left panels) and MDCK cells (center and right panels) treated with HGF alone (top panels, control) or HGF + <b>1</b> (1 Î¼M, lower panels). For PC3M cells, arrowheads indicate regions of cellular extension into the artificial wound. For MDCK cells, advancing lamellipodia observed in center panels are outlined in white in the right panels for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800523u&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51378" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51378" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We describe herein the synthesis and biochemical characterization of a biotinylated derivative of the Grb2-SH2 domain inhibitor <b>1</b> and used this as a tool to assess its SH2 domain binding selectivity. It is estimated that more than 100 different SH2 domains are present in the human genome,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> each of which recognizes phosphotyrosine (pTyr) in the context of three to five additional residues, usually carboxyl-terminal to pTyr.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Compound <b>1</b> is a peptidomimetic that was originally designed to mimic the sequence Asn-pTyr-Val-Asn-Ile-Ile-Glu, where pTyr has been substituted with a hydrolytically stable 4-(2â²-malonyl)phenylalanine residue.<a onclick="showRef(event, 'ref17 ref26'); return false;" href="javascript:void(0);" class="ref ref17 ref26">(17, 26)</a> Several studies have revealed the importance of Asn at the position Y + 2 within this sequence for selective recognition by the SH2 domain of Grb2. In addition to design criteria, it is essential to identify <i>bona fide</i> intracellular targets for synthetic antagonists of proteinâprotein interactions. Prior co-immunoprecipitation experiments provided indirect evidence that Grb2 is the primary target of <b>1</b> and that <b>1</b> was able to disrupt Grb2âEGFR and Grb2âc-Met interactions.<a onclick="showRef(event, 'ref11 ref27'); return false;" href="javascript:void(0);" class="ref ref11 ref27">(11, 27)</a></div><div class="NLM_p">As a more efficient and direct alternative to screening <b>1</b> for binding against all known SH2 domain containing proteins, we devised a capture strategy coupled with mass spectral analysis using a biotinylated analogue of the Grb2 SH2 domain binding antagonist <b>1</b>. This approach may be broadly useful to confirm the selectivity of small molecule protein binding within the growing field of targeted drug development. Biotin/streptavidin based capture combined with proteomic analysis should be a powerful tool for identifying adapter proteins along with their associated proteins.</div><div class="NLM_p last">The findings that Grb2 SH2 domain binding antagonists cause significant remodeling of the actin cytoskeleton and inhibit PAK1 further confirm the importance of Grb2 as a regulator of actin-based cell motility. Coincident with these effects, we have previously shown that treatment of cells with <b>1</b> disrupts HGF-stimulated physical association between Grb2 and focal adhesion kinase (FAK), thereby inhibiting focal adhesion formation.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Together, these results suggest that selective disruption of Grb2 SH2 domain-mediated signaling by a single agent may be a viable strategy to target several molecular events required for cell migration, which is critical to pathologic processes such as tumor invasion, tumor angiogenesis, and metastasis.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33544" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33544" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Surface Plasmon Resonance Analysis of DrugâProtein Binding</h3><div class="NLM_p last">Grb2 SH2 domain-binding experiments were performed on a Biacore T100 instrument (Biacore Inc., Piscataway, NJ) using methods reported previously.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> All biotinylated Grb2 SH2 domain proteins were expressed and purified by the Protein Expression Laboratory and Protein Chemistry Laboratory, SAIC-Frederick. For the T100 analysis using biotin-capture surfaces, streptavidin (Neutravidin, Pierce catalog number 31000) dissolved in 10 mM sodium acetate, pH 4.5, was immobilized onto carboxymethyl 5â² dextran surface (CM5 sensor chip, Biacore, Inc.) by amine coupling using the immobilization wizard supplied by the Biacore T100 software with a 5000 RU target on each of four flow cells. Lyophilized biotinylated Grb2 SH2 domain protein was reconstituted in 50% DMSO in H<sub>2</sub>O to make a stock solution of 1 mg/mL and stored at â80 Â°C. A 20 Î¼g aliquot of this solution was used for immobilization by diluting in 1Ã PBS (phosphate-buffered saline, pH 7.4), which was also used as the running buffer for Grb2 SH2 domain capture. A manual method for building a capture surface was used with a flow rate of 20 Î¼L/min and a capture target of 2500 RU for flow cells 2 and 4. Synthetic inhibitors were serially diluted in running buffer to concentrations ranging from 1.25 to 1500 nM and serially injected at 25 Â°C at a flow rate of 30 Î¼L/min for 2 min. Each concentration was followed by two blank buffer injections, and every injection was performed in duplicate within each experiment. To subtract background noise from each data set, all samples were also run over Neutravidin reference surfaces to allow double referencing. Data were fit to a simple 1:1 interaction model using the global data analysis program Scrubber (<a href="http://www.biologic.com.au/" class="extLink">http://www.biologic.com.au/</a>).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Protein Capture and Immunoblotting</h3><div class="NLM_p last">SK-LMS-1 cells were serum-deprived for 16 h, stimulated with recombinant human HGF (25 ng/mL; R&D Systems, Minneapolis, MN) for 20 min, and lysed in cold nonionic detergent containing buffer. Compound <b>3</b> (3 Î¼M) or <b>4</b> (3 Î¼M) was added, and the lysate was incubated on ice for 1 h. SA-coated beads (streptavidin on UltraLink resin, Pierce Biotechnology, Rockford, IL) were added, and lysates were mixed at 4 Â°C for 1 h. SA-coated beads were then washed 5 times in lysis buffer containing increasing concentrations of NaCl (150â500 mM), then stored at â80 Â°C in PBS. Samples were analyzed by SDSâPAGE and immunoblotting or, in parallel, subjected to exhaustive tryptic digestion for mass spectrometry analysis. Immunoblotting was performed as described using an anti-Grb2 antibody (Santa Cruz Biotech).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Mass Spectrometry</h3><div class="NLM_p last">Proteins captured on SA-coated beads were washed three times with 100 mM ammonium bicarbonate to exchange the buffer, reduced with 10 mM DTT for 1 h at 51 Â°C, and alkylated with 55 mM iodoacetamide for 45 min at 25 Â°C. The proteins were then digested with trypsin for 6 h at 25 Â°C with agitation. The beads were pelleted, and the supernatant was removed. Peptides in the supernatant were acidified by adding 0.1% formic acid. Separation of the peptides was performed at 500 nL/min and was coupled to online analysis by tandem mass spectrometry (nLCâESI-MS/MS) on an LTQ ion trap mass spectrometer (ThermoElectron, San Jose, CA) equipped with a nanospray ion source. From the eluted peptides, 10 Î¼L were loaded onto a 0.1 mm Ã 150 mm Magic C18AQ column (Michrom Bioresources, Inc., Auburn, CA) inline after a nanotrap column using the Paradigm MS4 MDLC (Michrom Bioresources, Inc., Auburn, CA). Elution of the peptides into the mass spectrometer was performed with a linear gradient from 95% mobile phase A (2% acetonitrile, 0.1% formic acid, 97.9% water) to 65% mobile phase B (10% water, 0.1% acetic acid, 89.9% acetonitrile) over 45 min and then to 95% mobile phase B in 5 min. The peptides were detected in positive ion mode using a data-dependent method in which the top seven ions detected in an initial survey scan were selected for MS/MS analysis. The MS/MS spectra were searched against the human NCBI database using TurboSEQUEST in BioWorks, version 3.2 (ThermoElectron, San Jose, CA).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Motility Assay</h3><div class="NLM_p last">Cell migration was measured using modified Boyden chambers as described.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> PC3M cells were seeded at 200â000 cells per chamber after treatment with the respective compounds for 24 h. Cell migration was stimulated using 50 ng/mL recombinant human HGF (R&D Systems, Minneapolis, MN). Mean values from four fields observed by light microscopy (1 Ã 1.4 mm) were calculated for each of triplicate wells per condition.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Immunofluorescence Videomicroscopy</h3><div class="NLM_p last">PC3M and MDCK cells plated in chamber slides were serum-deprived in the presence or absence of <b>1</b> (1 Î¼M) for 24 h. Cells were then removed from a small portion of the monolayer using a pipet tip to simulate wounding, and cells were incubated in the presence or absence of HGF (50 ng/mL) to stimulate motility prior to fixation and permeabilization. Slides were blocked with 5% bovine serum albumin in PBS for 1 h and then incubated overnight at 4 Â°C with Alexa488-conjugated phalloidin (Molecular Probes). Slides were washed with PBS, nuclei were stained with 4â²,6-diamidino-2-phenylindole (DAPI, Molecular Probes), and digital epifluorescence images were acquired using an inverted Olympus videomicroscope and IPLab software (Scanalytics).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Synthesis. Trifluoromethanesulfonic Acid 5-Hydroxynaphthalen-1-yl Ester (<b>6</b>)</h3><div class="NLM_p last">A solution of 5-dihydroxynaphthalene (10.18 g, 63.6 mmol), <i>N</i>-phenyltrifluoromethanesulfonimide (22.7 g, 63.6 mmol), 2,4,6-collidine (8.4 mL, 63.6 mmol), and DMAP (930 mg, 7.62 mmol) in CH<sub>2</sub>Cl<sub>2</sub>/DMF (240 mL, 19:5 v/v) was refluxed for 12 h. The solvent was evaporated in vacuo, and the residue was dissolved in EtOAc, washed with 5% HCl solution, H<sub>2</sub>O, brine, and dried over Na<sub>2</sub>SO<sub>4</sub>. After evaporation of solvent, the remaining residue was purified by silica gel flash chromatography to give <b>6</b> as brown solid (8.70 g, 47% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 10.70 (s, 1H), 8.27 (d, 1H, <i>J</i> = 8.4 Hz), 7.63 (d, 1H, <i>J</i> = 7.2 Hz), 7.59â7.54 (m, 2H), 7.35 (d, 1H, <i>J</i> = 8.4 Hz), 7.06 (d, 1H, <i>J</i> = 7.4 Hz). MS (FAB) <i>m</i>/<i>z</i> 291 [M â H]<sup>â</sup>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 3-(5-Hydroxynaphthalen-1-yl)acrylonitrile (<b>7</b>)</h3><div class="NLM_p last">To a solution of <b>6</b> (7.10 g, 24.2 mmol), acrylonitrile (3.3 mL, 50.1 mmol), and Et<sub>3</sub>N (7.5 mL, 50.1 mmol) were added Pd(OAc)<sub>2</sub> (146 mg, 0.66 mmol) and DPPP (296 mg, 0.66 mmol). The mixture was refluxed under argon (24 h), then cooled to room temperature, diluted with EtOAc, and filtered through Celite. The filtrate was washed with saturated NH<sub>4</sub>Cl solution and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. After evaporation of solvent, the remaining residue was purified by silica gel flash chromatography to provide <b>7</b> (2.33 g, 49% yield) as a yellow solid and <b>8</b> (1.52 g, 32% yield) as a yellow oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 8.28 (d, 1H, <i>J</i> = 8.5 Hz), 8.13 (d, 1H, <i>J</i> = 16.4 Hz), 7.53 (d, 1H, <i>J</i> = 8.6 Hz), 7.43â7.33 (m, 3H), 6.82 (d, 1H, <i>J</i> = 7.5 Hz), 5.89 (d, 1H, <i>J</i> = 16.4 Hz). MS (FAB) <i>m</i>/<i>z</i> 195 (M)<sup>+</sup>; 196 (MH)<sup>+</sup>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 5-(3-Aminopropyl)naphthalen-1-ol (<b>9</b>)</h3><div class="NLM_p last">Compound <b>7</b> (2.62 g, 13.4 mmol) was dissolved in THF (300 mL). To the stirred solution was added LiAlH<sub>4</sub> (1.09 g, 26.8 mmol) in several portions. The mixture was stirred at room temperature overnight. EtOAc (40 mL) was added followed by 10% NaOH<sub>aq</sub> (2 mL). The mixture was stirred for additional 1 h. After filtration, the filtrate was removed and the residue was purified by silica gel flash chromatography to provide <b>9</b> as a yellow oil (1.47 g, 54% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD) Î´ 8.09 (dd, 1H, <i>J</i> = 3.2 and 6.4 Hz), 7.51 (dd, 1H, <i>J</i> = 0.8 and 8.7 Hz), 7.31â7.25 (m, 3H), 6.80 (dd, 1H, <i>J</i> = 0.9 and 7.4 Hz), 3.05 (t, 2H, <i>J</i> = 7.8 Hz), 2.72 (t, 2H, <i>J</i> = 7.2 Hz). 1.92â1.85 (m, 2H); MS (FAB) <i>m</i>/<i>z</i> 202 (MH)<sup>+</sup>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (<i>S</i>)-<i>tert</i>-Butyl 4-Amino-1-(3-(5-hydroxynaphthalen-1-yl)propylamino)-1,4-dioxobutan-2-ylcarbamate (<i>N</i>-Boc Asn-<b>9</b>)</h3><div class="NLM_p last">To a solution of <b>9</b> (874 mg, 4.34 mmol) in DMF (21 mL) was added an active ester solution prepared by the reaction of <i>N-</i>Boc-Asn-OH (1.00 g, 4.34 mmol), HOBt (586 mg, 4.34 mmol), and <i>N,N</i>â²-diisopropylcarbodiimide (DIPCDI) (0.682 mL, 4.34 mmol) in DMF (14 mL) at room temperature for 10 min. The resulting solution was stirred at room temperature (12 h). Solvent was evaporated, and the remaining residue was dissolved in EtOAc, washed with H<sub>2</sub>O, brine, and dried over Na<sub>2</sub>SO<sub>4</sub>. After evaporation of solvent, the remaining residue was purified by silica gel flash chromatography to provide <i>N</i>-Boc Asn-<b>9</b> (1.56 g, 87% yield) as a yellow oil. <sup>1</sup>H NMR (CD<sub>3</sub>OD) Î´ 8.08 (m, 1H), 7.52 (d, 1H, <i>J</i> = 8.5 Hz), 7.32â7.27 (m, 3H), 6.80 (d, 1H, <i>J</i> = 7.5 Hz), 4.42 (m, 1H), 3.32â3.26 (m, 2H), 3.04 (t, 2H, <i>J</i> = 7.8 Hz), 2.68â2.61 (m, 2H), 1.91 (t, 2H, <i>J</i> = 7.4 Hz), 1.43 (s, 9H). MS (FAB) <i>m</i>/<i>z</i> 416 (MH)<sup>+</sup>. HRMS calcd for C<sub>22</sub>H<sub>30</sub>N<sub>3</sub>O<sub>5</sub> (M + H)<sup>+</sup>, 416.2185; found, 416.2183.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (2<i>S</i>)-2-Amino-<i>N</i><sup>1</sup>-[3-(5-hydroxynaphthalen-1-yl)propyl]succinamide (<i>N</i>-Asn-<b>9</b>)</h3><div class="NLM_p last"><i>N</i>-Boc Asn-<b>9</b> (1.56 g, 3.76 mmol) was dissolved in TFAâCH<sub>2</sub>Cl<sub>2</sub> (8 mL, 1:1 v/v), and the resulting solution was stirred at room temperature for 1 h. After evaporation of solvent, the remaining residue was purified by silica gel flash chromatography to provide <i>N</i>-Asn-<b>9</b> as a yellow oil (936 mg, 79% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD) Î´ 8.08 (dd, 1H, <i>J</i> = 3.2 and 6.6 Hz), 7.53 (d, 1H, <i>J</i> = 8.5 Hz), 7.32â7.27 (m, 3H), 6.80 (dd, 1H, <i>J</i> = 0.6 and 7.5 Hz), 3.70 (dd, 1H, <i>J</i> = 5.0 and 8.1 Hz), 3.15â3.05 (m, 3H), 2.64 (dd, 1H, <i>J</i> = 5.0 and 15.4 Hz), 2.48 (dd, 1H, <i>J</i> = 8.1 and 15.4 Hz), 1.98â1.91 (m, 2H). MS (FAB) <i>m</i>/<i>z</i> 316 (MH)<sup>+</sup>. HRMS calculated for C<sub>17</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup>, 316.1675; found, 316.1661.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (<i>S</i>)-(9<i>H</i>-Fluoren-9-yl)methyl 1-(4-Amino-1-(3-(5-hydroxynaphthalen-1-yl)propylamino)-1,4-dioxobutan-2-ylcarbamoyl)cyclohexylcarbamate (<i>N</i>-Fmoc <b>10</b>)</h3><div class="NLM_p last"><i>N</i>-Asn-<b>9</b> (901 mg, 2.86 mmol), <i>N</i>-Fmoc-1-aminocyclohexenecarboxylic acid (1.043 g, 2.86 mmol), HOBt (390 mg, 2.86 mmol), and DIPCDI (0.451 mL, 2.86 mmol) were treated as the preparative procedure of <i>N</i>-Boc Asn-<b>9</b> to provide <i>N</i>-Fmoc-protected <b>10</b> as a yellow solid (1.49 g, 79% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD) Î´ 8.30 (d, 1 H, <i>J</i> = 8.1 Hz), 8.05 (dd, 1H, <i>J</i> = 2.0 and 7.7 Hz), 7.82 (m, 1H). 7.74 (dd, 1 H, <i>J</i> = 3.3 and 7.5 Hz), 7.50â7.42 (m, 3H), 7.36â7.31 (m, 3 H), 7.26â7.18 (m, 5H), 6.78 (dd, 1H, <i>J</i> = 0.7 and 7.5 Hz), 4.62 (m, 1H), 4.34 (dd, 1H, <i>J</i> = 6.5 and 10.6 Hz), 4.22 (dd, 1H, <i>J</i> = 6.2 and 10.7 Hz), 4.05 (t, 1H, <i>J</i> = 6.1 Hz), 3.27â3.21 (m, 2H), 3.00 (t, 2H, <i>J</i> = 7.8 Hz), 2.86 (dd, 1H, <i>J</i> = 6.7 and 15.5 Hz), 2.71 (dd, 1H, <i>J</i> = 4.7 and 15.7 Hz), 1.96â1.83 (m, 5H), 1.75â1.27 (m, 7H). MS (FAB) <i>m</i>/<i>z</i> 663 (MH)<sup>+</sup>. HRMS calcd for C<sub>39</sub>H<sub>42</sub>N<sub>4</sub>O<sub>6</sub>Na (M + Na)<sup>+</sup>, 685.2997; found, 685.3012.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (2<i>S</i>)-2-[(1-Aminocyclohexanecarbonyl)amino]-<i>N</i><sup>1</sup>-[3-(5-hydroxynaphthalen-1-yl)propyl]succinamide (<b>10</b>)</h3><div class="NLM_p last">To a solution of <i>N</i>-Fmoc-protected <b>10</b> (1.49 g, 2.25 mmol) in CH<sub>3</sub>CN (30 mL) was added piperidine (3 mL), and the resulting solution was stirred at room temperature for 2 h. After evaporation of solvent, the remaining residue was purified by silica gel flash chromatography to provide <b>10</b> as a yellow solid (847 mg, 86% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD) Î´ 8.07 (dd, 1H, <i>J</i> = 3.1 and 6.3 Hz), 7.52 (d, 1H, <i>J</i> = 8.6 Hz), 7.34â7.27 (m, 3 H), 6.80 (dd, 1H, <i>J</i> = 0.7 and 7.5 Hz), 4.65 (dd, 1H, <i>J</i> = 5.9 and 6.6 Hz), 3.30â3.27 (m, 2H), 3.07â3.03 (m, 2H), 2.73 (dd, 1H, <i>J</i> = 6.7 and 15.4 Hz), 2.66 (dd, 1H, <i>J</i> = 5.9 and 15.4 Hz), 1.96â1.81 (m, 4H), 1.63â1.53 (m, 5H), 1.46â1.27 (m, 3H). MS (FAB) <i>m</i>/<i>z</i> 441 (MH)<sup>+</sup>. HRMS calcd for C<sub>24</sub>H<sub>33</sub>N<sub>4</sub>O<sub>4</sub> (M + H)<sup>+</sup>, 441.2502; found, 441.2505.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 2-{4-[2-(1-(1<i>S</i>)-{2-Carbamoyl-1-[3-(5-hydroxynaphthalen-1-yl)propylcarbamoyl]ethylcarbamoyl}cyclohexylcarbamoyl)-2-(2<i>S</i>)-(9<i>H</i>-fluoren-9-ylmethoxycarbonyl amino)ethyl]phenyl}malonic Acid Di-<i>tert</i>-butyl Ester (<b>12a</b>)</h3><div class="NLM_p last">Compound <b>10</b> (603 mg, 1.37 mmol), compound <b>11a</b> (826 mg, 1.37 mmol), HOBt (185 mg, 1.37 mmol), and DIPCDI (0.215 mL, 1.37 mmol) were treated as the preparative procedure of <i>N</i>-Boc Asn-<b>9</b> to provide <b>12a</b> as a yellow solid (1.058 g, 79% effective yield based on 247 mg of recovered <b>10</b>). <sup>1</sup>H NMR (CD<sub>3</sub>OD) Î´ 8.18 (d, 1H, <i>J</i> = 7.8 Hz), 8.05 (d, 1H, <i>J</i> = 9.1 Hz), 7.82â7.75 (m, 3H), 7.56â7.51 (m, 3H), 7.36â7.18 (m, 9H), 7.77 (d, 1H, <i>J</i> = 7.5 Hz), 4.52 (m, 1H), 4.45 (s, 1H), 4.42 (m, 1H), 4.32â4.21 (m, 2H), 4.08 (t, 1H, <i>J</i> = 6.7 Hz), 3.27â3.21 (m, 2H), 3.07â3.02 (m, 3H), 2.93â2.84 (m, 2H), 2.79 (dd, 1H, <i>J</i> = 5.5 and 14.8 Hz), 1.99â1.92 (m, 4H), 1.77â1.70 (m, 2H), 1.44 (s, 18H), 1.42â1.24 (m, 4H). MS (FAB) <i>m</i>/<i>z</i> 1024.5 (MH)<sup>+</sup>. HRMS calcd for C<sub>59</sub>H<sub>69</sub>N<sub>5</sub>O<sub>11</sub>Na (M + Na)<sup>+</sup>, 1046.4886; found, 1046.4886.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> [2-(4-<i>tert</i>-Butoxyphenyl)-1-(1<i>S</i>)-{2-carbamoyl-1-[3-(5-hydroxynaphthalen-1-yl)propylcarbamoyl]ethylcarbamoyl}cyclohexylcarbamoyl)ethyl]carbamic Acid 9<i>H</i>-Fluoren-9-ylmethyl Ester (<b>12b</b>)</h3><div class="NLM_p last">Compound <b>10</b> (185 mg, 0.42 mmol), compound <b>11b</b> (230 mg, 0.50 mmol), HOBt (68 mg, 0.50 mmol), and DIPCDI (0.079 mL, 0.50 mmol) were treated as the preparative procedure of <i>N</i>-Boc Asn-<b>9</b> to provide <b>12b</b> as a yellow solid (274 mg, 74% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 8.02â7.95 (m, 2H), 7.69â7.60 (m, 2H), 7.42â7.38 (m, 2H), 7.32â7.28 (m, 2H), 7.21â7.17 (m, 6H), 7.00 (t, 1H, <i>J</i> = 7.5 Hz), 6.90â6.86 (m, 2H), 6.79â6.76 (m, 2H), 6.67 (d, 1H, <i>J</i> = 7.3 Hz), 4.60 (m, 1H), 4.30â4.25 (m, 3H), 4.03 (m, 1H), 3.32â3.21 (m, 2H), 2.98â2.89 (m, 2H), 2.74 (m, 1H), 2.48 (m, 1H), 2.02â1.06 (m, 14H), 1.22 (s, 9H). MS (FAB) <i>m</i>/<i>z</i> 882 (MH)<sup>+</sup>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-{4-[2-(2<i>S</i>)-(<i>tert</i>-Butoxyoxalylamino)-2-(1-(1<i>S</i>)-{2-carbamoyl-1-[3-(5-hydroxy-naphthalen-1-yl)propylcarbamoyl]ethylcarbamoyl}cyclohexylcarbamoyl)ethyl]phenyl}malonic Acid Di-<i>tert</i>-butyl Ester (<b>13a</b>)</h3><div class="NLM_p last">Compound <b>12a</b> (609 mg, 0.595 mmol) and piperidine (0.47 mL) were treated as preparative procedure of <b>10</b> to provide deprotected Fmoc <b>12a</b> (477 mg). To a solution of this crude material (477 mg, 0.595 mmol) in DMF (24 mL) was added <sup><i>i</i></sup>Pr<sub>2</sub>NEt (0.124 mL, 0.714 mmol) and <i>tert</i>-butyloxalyl (0.091 mL, 0.714 mmol) at 0 Â°C. The solution was stirred at room temperature overnight. After evaporation of solvent, the remaining residue was purified by silica gel flash chromatography to provide <b>13a</b> as a yellow oil (240 mg, 43% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 8.05â8.01 (m, 2H), 7.65â7.61 (m, 2H), 7.46 (d, 1H, <i>J</i> = 8.6 Hz), 7.27â7.25 (m, 4H), 7.08 (t, 1H, <i>J</i> = 8.0 Hz), 7.04â7.01 (m, 2H), 6.74 (s, 1H), 6.62 (d, 1H, <i>J</i> = 7.3 Hz), 6.46 (s, 1H), 5.58 (s, 1H), 4.67 (m, 1H), 4.56 (m, 1H), 4.41 (s, 1H), 3.39 (m, 1H), 3.28 (m, 1H), 3.05â2.95 (m, 4H), 2.85 (dd, 1H, <i>J</i> = 8.2 and 14.3 Hz), 2.46 (dd, 1H, <i>J</i> = 4.9 and 15.0 Hz), 2.00â1.62 (m, 8H), 1.47 (s, 9H), 1.46 (s, 9H), 1.45 (s, 9H), 1.44â1.24 (m, 4H). MS (FAB) <i>m</i>/<i>z</i> 930 (MH)<sup>+</sup>.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-[2-(4-<i>tert</i>-Butoxyphenyl)-(1-(1<i>S</i>)-{2-carbamoyl-1-[3-(5-hydroxynaphthalen-1-yl)propylcarbamoyl]ethylcarbamoyl}cyclohexylcarbamoyl)ethyl]oxalamic Acid <i>tert</i>-Butyl Ester (<b>13b</b>)</h3><div class="NLM_p last">Compound <b>12b</b> (258 mg, 0.293 mmol) was treated as preparative procedure of <b>13a</b> to provide <b>13b</b> as a yellow oil (174 mg, 80% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD) Î´ 8.03 (d, 1H, <i>J</i> = 8.2 Hz), 7.52 (d, 1H, <i>J</i> = 8.5 Hz), 7.32â7.21 (m, 3H), 7.05â7.02 (m, 2H), 6.85â6.81 (m, 2H), 6.75 (dd, 1H, <i>J</i> = 0.7 and 7.5 Hz), 4.63 (dd, 1H, <i>J</i> = 6.9 and 8.5 Hz), 4.52 (dd, 1H, <i>J</i> = 5.0 and 7.2 Hz), 3.37â3.21 (m, 2H), 3.11â3.03 (m, 3H), 2.91 (dd, 1H, <i>J</i> = 8.6 and 14.0 Hz), 2.86 (dd, 1H, <i>J</i> = 7.2 and 15.4 Hz), 2.71 (dd, 1H, <i>J</i> = 5.0 and 15.5 Hz), 1.98â1.18 (m, 12H), 1.42 (s, 9H), 1.26 (s, 9H). MS (FAB) <i>m</i>/<i>z</i> 788 (MH)<sup>+</sup>.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-{4-[2-(1-(1<i>S</i>)-{2-Carbamoyl-1-[3-(5-hydroxy-naphthalen-1-yl)propylcarbamoyl]ethylcarbamoyl}cyclohexylcarbamoyl)-2-(2<i>S</i>)-(oxalylamino)ethyl]phenyl}malonic Acid (<b>2</b>)</h3><div class="NLM_p last">A solution of <b>13a</b> (110 mg, 0.118 mmol) in a mixture of TFAâTESâH<sub>2</sub>O (2.0 mL, 3.7:0.1:0.2 v/v) was stirred at room temperature for 1 h. After evaporation of solvent, the remaining residue was purified by HPLC as follows: a linear gradient over 25 min of from 0.1% TFA in 5% CH<sub>3</sub>CN/95% H<sub>2</sub>O to 0.1% TFA in 95% CH<sub>3</sub>CN/5% H<sub>2</sub>O; analytical retention time = 24.4 min; preparative retention time = 14.1 min. Lyophilization provided <b>2</b> as a yellow solid (38 mg, 42% yield) in 97.6% purity as determined by HPLC. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 9.92 (s, 1H), 8.73 (d, 1H, <i>J</i> = 7.8 Hz), 8.22 (s, 1H), 7.93â7.89 (m, 2H), 7.43â7.40 (m, 2H), 7.29â7.15 (m, 9H), 6.83 (s, 1H), 6.77 (d, 1H, <i>J</i> = 7.3 Hz), 4.66 (m, 1H), 4.52 (s, 1H), 4.30 (m, 1H), 3.12â3.08 (m, 3H), 2.95â2.89 (m, 3H), 2.61 (dd, 1H, <i>J</i> = 6.5 and 15.5 Hz), 2.43 (dd, 1H, <i>J</i> = 7.0 and 15.5 Hz), 1.91â1.08 (m, 12H). MS (FAB) <i>m</i>/<i>z</i> 761 (M)<sup>+</sup>, 760 (M â H)<sup>â</sup>. HRMS calcd for C<sub>38</sub>H<sub>43</sub>N<sub>5</sub>O<sub>12</sub>Na (M â 2Na + 3H)<sup>+</sup>, 784.2800; found, 784.2810.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (4<i>R</i>,5<i>S</i>,6<i>S</i>)-2-{4-[2-(1-{2-Carbamoyl-1-[3-(3<i>S</i>)-(5-{6-[5-(2-oxohexahydrothieno[3,4-<i>d</i>]imidazol-6-yl)pentanoylamino]hexanoyloxy}naphthalen-1-yl)propylcarbamoyl}cyclohexylcarbamoyl)-2-(2<i>S</i>)-(oxalylamino)ethyl]phenyl}malonic Acid Tri-<i>tert</i>-butyl Ester (<b>14a</b>)</h3><div class="NLM_p last">To a solution of <b>13a</b> (119 mg, 0.13 mmol) and 6-biotinamidocaproic acid (94 mg, 0.26 mmol) in DMF (7 mL) was added EDC (50 mg, 0.26 mmol) and DMAP (2.4 mg, 0.02 mmol) at 0 Â°C, and the resulting solution was stirred at room temperature for 12 h. The solvent was evaporated, and the residue was dissolved in EtOAc, washed with H<sub>2</sub>O, brine, and dried over Na<sub>2</sub>SO<sub>4</sub>. After evaporation of the solvent, the remaining residue was purified by silica gel flash chromatography to provide <b>14a</b> as a white solid (127 mg, 78% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD) Î´ 7.71 (dd, 1H, <i>J</i> = 1.5 and 7.6 Hz), 7.50â7.39 (m, 4H), 7.29â7.19 (m, 5H), 4.72 (dd, 1H, <i>J</i> = 6.7 and 8.5 Hz), 4.57 (dd, 1H, <i>J</i> = 5.0 and 7.1 Hz), 4.47 (s, 1H), 4.46 (m, 1H), 4.32 (dd, 1H, <i>J</i> = 4.8 and 7.7 Hz), 4.27 (dd, 1H, <i>J</i> = 4.4 and 7.8 Hz), 4.13 (dd, 1H, <i>J</i> = 4.4 and 7.9 Hz), 3.35â3.32 (m, 2H), 3.23â3.05 (m, 5H), 2.93â2.77 (m, 5H), 2.70â2.62 (m, 3H), 2.21â2.17 (m, 3H), 2.03â1.94 (m, 3H), 1.86â1.48 (m, 24H), 1.45 (s, 9H), 1.44 (s, 18H). MS (FAB) <i>m</i>/<i>z</i> 1269 (MH)<sup>+</sup>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (4<i>R</i>,5<i>S</i>,6<i>S</i>)-6-[5-(2-Oxohexahydrothieno[3,4-<i>d</i>]imidazol-6-yl)pentanoylamino]hexanoic Acid 5-{3-{2-({1-2(<i>tert</i>-butoxyoxylylamino)-3-(4-<i>tert</i>-butoxyphenyl)propionylamino]cyclohexylcarbonyl}amino)-3-carbamoylpropionylamino]propyl}naphthalen-1-yl Ester (<b>14b</b>)</h3><div class="NLM_p last">Compound <b>13b</b> (80 mg, 0.10 mmol) was treated as preparative procedure of <b>14a</b> to provide <b>14b</b> as a white solid (9 mg, 42% effective yield based on 65 mg of recovered <b>13b</b>). <sup>1</sup>H NMR (CD<sub>3</sub>OD) Î´ 8.04 (d, 1H, <i>J</i> = 8.6 Hz), 7.71 (dd, 1H, <i>J</i> = 1.7 and 7.5 Hz), 7.51â7.40 (m, 3H), 7.19 (d, 1H, <i>J</i> = 7.0 Hz), 7.11â7.08 (m, 2H), 6.89â6.85 (m, 2H), 4.68 (dd, 1H, <i>J</i> = 6.8 and 8.6 Hz), 4.56 (dd, 1H, <i>J</i> = 5.0 and 7.1 Hz), 4.32 (dd, 1H, <i>J</i> = 4.7 and 8.2 Hz), 4.13 (dd, 1H, <i>J</i> = 4.5 and 7.8 Hz), 3.40â3.21 (m, 4H), 3.17â3.10 (m, 4H), 2.99â2.61 (m, 7H), 2.18 (t, 2H, <i>J</i> = 7.3 Hz), 2.02â1.24 (m, 24H), 1.45 (s, 9H), 1.30 (s, 9H). MS (FAB) <i>m</i>/<i>z</i> 1127 (MH)<sup>+</sup>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (4<i>R</i>,5<i>S</i>,6<i>S</i>)-2-{4-[2-(1-{2-Carbamoyl-1-[3-(3<i>S</i>)-(5-{6-[5-(2-oxohexahydrothieno[3,4-<i>d</i>]imidazol-6-yl)pentanoylamino]hexanoyloxy}naphthalen-1-yl)propylcarbamoyl}cyclohexylcarbamoyl)-2-(2<i>S</i>)-(oxalylamino)ethyl]phenyl}malonic Acid (<b>3</b>)</h3><div class="NLM_p last">A solution of <b>14a</b> (127 mg, 0.1 mmol) in a mixture of TFAâethaneditholâH<sub>2</sub>O (1.0 mL, 3.8:0.1:0.1 v/v) was stirred at room temperature for 1 h. The mixture was reduced under vacuum to a volume of 0.25 mL. Diethyl ether (10 mL) was added, giving a white solid. The solid was collected and purified by HPLC as follows: a linear gradient over 25 min from 0.1% TFA in 5% CH<sub>3</sub>CN/95% H<sub>2</sub>O to 0.1% TFA in 95% CH<sub>3</sub>CN/5% H<sub>2</sub>O; analytical retention time = 24.6 min; preparative retention time = 16.6 min. Liophilization provided <b>3</b> as a white solid (44.7 mg, 41% yield) in 99% purity as determined by HPLC. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 8.75 (d, 1H, <i>J</i> = 7.8 Hz), 8.24 (s, 1H), 7.93 (t, 2H, <i>J</i> = 8.2 Hz), 7.71 (t, 1H, <i>J</i> = 5.6 Hz), 7.63 (t, 1H, <i>J</i> = 4.8 Hz), 7.45â7.41 (m, 2H), 7.37â7.35 (m, 2H), 7.30 (s, 1H), 7.20â7.15 (m, 5H), 6.84 (s, 1H), 6.34 (s, 1H), 4.66 (m, 1H), 4.52 (m, 1H), 4.31 (m, 1H), 4.21 (dd, 1H, <i>J</i> = 5.0 and 7.7 Hz), 4.04 (dd, 1H, <i>J</i> = 4.4 and 7.7 Hz), 3.13â3.07 (m, 3H), 3.04â2.93 (m, 6H), 2.75â2.69 (m, 3H), 2.62 (dd, 1H, <i>J</i> = 6.2 and 15.5 Hz), 2.51â2.45 (m, 2H), 1.99 (t, 2H, <i>J</i> = 7.4 Hz), 1.92â1.08 (m, 24H). MS (FAB) <i>m</i>/<i>z</i> 1100 (M)<sup>+</sup>, 1099 (M â H)<sup>â</sup>. HRMS calcd for C<sub>54</sub>H<sub>65</sub>N<sub>8</sub>O<sub>15</sub>Na<sub>3</sub>S (M â 3Na + 4H)<sup>+</sup>, 1101.4598; found, 1101.4502.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (4<i>R</i>,5<i>S</i>,6<i>S</i>)-6-[5-(2-Oxohexahydrothieno[3,4-<i>d</i>]imidazol-6-yl)pentanoylamino]hexanoic Acid 5-{3-[3-Carbamoyl-2-({1-[3-(4-hydroxyphenyl)-2-(oxylylamino)propionylamino]cyclohexylcarbonyl}amino)propionylamino]propyl}naphthalen-1-yl Ester (<b>4</b>)</h3><div class="NLM_p last">Compound <b>14b</b> (9.0 mg) was treated as preparative procedure of <b>14a</b> to provide <b>4</b> as a white solid (4.5 mg, 56% yield). Analytical retention time = 26.0 min; preparative retention time = 18.1 min (HPLC conditions as indicated for <b>14a</b>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 8.58 (d, 1H, <i>J</i> = 7.8 Hz), 8.19 (s, 1H), 7.95 (d, 1H, <i>J</i> = 8.8 Hz), 7.88 (d, 1H, <i>J</i> = 7.6 Hz), 7.71 (m, 1H), 7.64 (m, 1H), 7.45 (d, 2H, <i>J</i> = 7.3 Hz), 7.40â7.36 (m, 2H), 7.30 (s, 1H), 7.19 (d, 1H, <i>J</i> = 7.4 Hz), 6.95 (d, 2H, <i>J</i> = 7.4 Hz), 6.83 (s, 1H), 6.55 (d, 2H, <i>J</i> = 7.0 Hz), 6.38â6.32 (m, 2H), 4.56 (m, 1H), 4.31 (m, 1H), 4.21 (m, 1H), 4.04 (dd, 1H, <i>J</i> = 4.6 and 7.5 Hz), 3.16â2.96 (m, 9H), 2.81â2.69 (m, 3H), 2.60 (dd, 1H, <i>J</i> = 6.7 and 15.5 Hz), 2.61â2.56 (m, 2H), 2.01â1.10 (m, 26H). MS (FAB) <i>m</i>/<i>z</i> 1013 (M â H)<sup>â</sup>.</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76110" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76110" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald P. Bottaro</span> - <span class="hlFld-Affiliation affiliation">Urologic Oncology Branch and Laboratory of Cell Biology, National Cancer Institute, Bethesda, Maryland 20892, Laboratory of Medicinal Chemistry, National Cancer Institute at Frederick, Frederick, Maryland 21702 and Protein Chemistry Laboratory-SAIC, Frederick, Maryland 21702</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b9dddbd6cdcdd8cbd6f9d1dcd5d0c197d7d0d197ded6cf"><span class="__cf_email__" data-cfemail="7115131e050510031e3119141d18095f1f18195f161e07">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessio Giubellino</span> - <span class="hlFld-Affiliation affiliation">Urologic Oncology Branch and Laboratory of Cell Biology, National Cancer Institute, Bethesda, Maryland 20892, Laboratory of Medicinal Chemistry, National Cancer Institute at Frederick, Frederick, Maryland 21702 and Protein Chemistry Laboratory-SAIC, Frederick, Maryland 21702</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhen-Dan Shi</span> - <span class="hlFld-Affiliation affiliation">Urologic Oncology Branch and Laboratory of Cell Biology, National Cancer Institute, Bethesda, Maryland 20892, Laboratory of Medicinal Chemistry, National Cancer Institute at Frederick, Frederick, Maryland 21702 and Protein Chemistry Laboratory-SAIC, Frederick, Maryland 21702</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa M. Miller Jenkins</span> - <span class="hlFld-Affiliation affiliation">Urologic Oncology Branch and Laboratory of Cell Biology, National Cancer Institute, Bethesda, Maryland 20892, Laboratory of Medicinal Chemistry, National Cancer Institute at Frederick, Frederick, Maryland 21702 and Protein Chemistry Laboratory-SAIC, Frederick, Maryland 21702</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen M. Worthy</span> - <span class="hlFld-Affiliation affiliation">Urologic Oncology Branch and Laboratory of Cell Biology, National Cancer Institute, Bethesda, Maryland 20892, Laboratory of Medicinal Chemistry, National Cancer Institute at Frederick, Frederick, Maryland 21702 and Protein Chemistry Laboratory-SAIC, Frederick, Maryland 21702</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lakshman K. Bindu</span> - <span class="hlFld-Affiliation affiliation">Urologic Oncology Branch and Laboratory of Cell Biology, National Cancer Institute, Bethesda, Maryland 20892, Laboratory of Medicinal Chemistry, National Cancer Institute at Frederick, Frederick, Maryland 21702 and Protein Chemistry Laboratory-SAIC, Frederick, Maryland 21702</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gagani Athauda</span> - <span class="hlFld-Affiliation affiliation">Urologic Oncology Branch and Laboratory of Cell Biology, National Cancer Institute, Bethesda, Maryland 20892, Laboratory of Medicinal Chemistry, National Cancer Institute at Frederick, Frederick, Maryland 21702 and Protein Chemistry Laboratory-SAIC, Frederick, Maryland 21702</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benedetta Peruzzi</span> - <span class="hlFld-Affiliation affiliation">Urologic Oncology Branch and Laboratory of Cell Biology, National Cancer Institute, Bethesda, Maryland 20892, Laboratory of Medicinal Chemistry, National Cancer Institute at Frederick, Frederick, Maryland 21702 and Protein Chemistry Laboratory-SAIC, Frederick, Maryland 21702</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert J. Fisher</span> - <span class="hlFld-Affiliation affiliation">Urologic Oncology Branch and Laboratory of Cell Biology, National Cancer Institute, Bethesda, Maryland 20892, Laboratory of Medicinal Chemistry, National Cancer Institute at Frederick, Frederick, Maryland 21702 and Protein Chemistry Laboratory-SAIC, Frederick, Maryland 21702</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ettore Appella</span> - <span class="hlFld-Affiliation affiliation">Urologic Oncology Branch and Laboratory of Cell Biology, National Cancer Institute, Bethesda, Maryland 20892, Laboratory of Medicinal Chemistry, National Cancer Institute at Frederick, Frederick, Maryland 21702 and Protein Chemistry Laboratory-SAIC, Frederick, Maryland 21702</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Terrence R. Burke</span> - <span class="hlFld-Affiliation affiliation">Urologic Oncology Branch and Laboratory of Cell Biology, National Cancer Institute, Bethesda, Maryland 20892, Laboratory of Medicinal Chemistry, National Cancer Institute at Frederick, Frederick, Maryland 21702 and Protein Chemistry Laboratory-SAIC, Frederick, Maryland 21702</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm800523u" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42551" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42551" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61764" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61764" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 28 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Blume-Jensen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span> </span><span class="NLM_article-title">Oncogenic kinase signalling</span> <span class="citation_source-journal">Nature</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">411</span> <span class="NLM_fpage">355</span> <span class="NLM_lpage">365</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1038%2F35077225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=11357143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVSjsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=355-365&author=P.+Blume-Jensenauthor=T.+Hunter&title=Oncogenic+kinase+signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic kinase signaling</span></div><div class="casAuthors">Blume-Jensen, Peter; Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">411</span>
        (<span class="NLM_cas:issue">6835</span>),
    <span class="NLM_cas:pages">355-365</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 93 refs.  Protein-tyrosine kinases (PTKs) are important regulators of intracellular signal-transduction pathways mediating development and multicellular communication in metazoans.  Their activity is normally tightly controlled and regulated.  Perturbation of PTK signaling by mutations and other genetic alterations results in deregulated kinase activity and malignant transformation.  The lipid kinase phosphoinositide 3-OH kinase (PI(3)K) and some of its downstream targets, such as the protein-serine/threonine kinases Akt and p70 S6 kinase (p70S6K), are crucial effectors in oncogenic PTK signaling.  This review emphasizes how oncogenic conversion of protein kinases results from perturbation of the normal autoinhibitory constraints on kinase activity and provides an update on our knowledge about the role of deregulated PI(3)K/Akt and mammalian target of rapamycin/p70S6K signaling in human malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJiBzQk4vjZbVg90H21EOLACvtfcHk0lgP0lOAUcvd1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVSjsr0%253D&md5=cd1bce803c2daadb98cbdba8550be43b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F35077225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35077225%26sid%3Dliteratum%253Aachs%26aulast%3DBlume-Jensen%26aufirst%3DP.%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DOncogenic%2520kinase%2520signalling%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D355%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lowenstein, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batzer, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skolnik, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Sagi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span> </span><span class="NLM_article-title">The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling</span> <span class="citation_source-journal">Cell</span><span class="NLM_year" style="font-weight: bold;">1992</span> <span class="NLM_volume">70</span> <span class="NLM_fpage">431</span> <span class="NLM_lpage">442</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1016%2F0092-8674%2892%2990167-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=1322798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1ajtbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1992&pages=431-442&author=E.+J.+Lowensteinauthor=R.+J.+Dalyauthor=A.+G.+Batzerauthor=W.+Liauthor=B.+Margolisauthor=R.+Lammersauthor=A.+Ullrichauthor=E.+Y.+Skolnikauthor=D.+Bar-Sagiauthor=J.+Schlessinger&title=The+SH2+and+SH3+domain-containing+protein+GRB2+links+receptor+tyrosine+kinases+to+ras+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling</span></div><div class="casAuthors">Lowenstein, E. J.; Daly, R. J.; Batzer, A. G.; Li, W.; Margolis, B.; Lammers, R.; Ullrich, A.; Skolnik, E. Y.; Bar-Sagi, D.; Schlessinger, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">431-42</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">A cDNA clone encoding a novel, widely expressed protein (called growth factor receptor-bound protein 2 or GRB2) contg. one src homol. 2 (SH2) domain and two SH3 domains was isolated.  Immunoblotting expts. indicate that GRB2 assocs. with tyrosine-phosphorylated epidermal growth factor receptors (EGFRs) and platelet-derived growth factor receptors (PDGFRs) via its SH2 domain.  Interestingly, GRB2 exhibits striking structural and functional homol. to the Caenorhabditis elegans protein sem-5.  To examine whether GRB2 is also a component of ras signaling in mammalian cells, microinjection studies were performed.  While injection of GRB2 or H-ras proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of GRB2 together with H-ras protein stimulated DNA synthesis.  These results suggest that GRB2/sem-5 plays a crucial role in a highly conserved mechanism for growth factor control of ras signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo0LYdxA1IuLVg90H21EOLACvtfcHk0lgP0lOAUcvd1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1ajtbg%253D&md5=86885e1cbee3f637ae9470aa9f8c264e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2892%2990167-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252892%252990167-B%26sid%3Dliteratum%253Aachs%26aulast%3DLowenstein%26aufirst%3DE.%2BJ.%26aulast%3DDaly%26aufirst%3DR.%2BJ.%26aulast%3DBatzer%26aufirst%3DA.%2BG.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMargolis%26aufirst%3DB.%26aulast%3DLammers%26aufirst%3DR.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DSkolnik%26aufirst%3DE.%2BY.%26aulast%3DBar-Sagi%26aufirst%3DD.%26aulast%3DSchlessinger%26aufirst%3DJ.%26atitle%3DThe%2520SH2%2520and%2520SH3%2520domain-containing%2520protein%2520GRB2%2520links%2520receptor%2520tyrosine%2520kinases%2520to%2520ras%2520signaling%26jtitle%3DCell%26date%3D1992%26volume%3D70%26spage%3D431%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Songyang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGlade, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bustelo, X. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanafusa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, T.</span><span> </span><span class="NLM_article-title">Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_year" style="font-weight: bold;">1994</span> <span class="NLM_volume">14</span> <span class="NLM_fpage">2777</span> <span class="NLM_lpage">2785</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1128%2FMCB.14.4.2777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=7511210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADyaK2cXktVenur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1994&pages=2777-2785&author=Z.+Songyangauthor=S.+E.+Shoelsonauthor=J.+McGladeauthor=P.+Olivierauthor=T.+Pawsonauthor=X.+R.+Busteloauthor=M.+Barbacidauthor=H.+Sabeauthor=H.+Hanafusaauthor=T.+Yi&title=Specific+motifs+recognized+by+the+SH2+domains+of+Csk%2C+3BP2%2C+fps%2Ffes%2C+GRB-2%2C+HCP%2C+SHC%2C+Syk%2C+and+Vav"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav</span></div><div class="casAuthors">Songyang, Z.; Shoelson, S. E.; McGlade, J.; Olivier, P.; Pawson, T.; Bustelo, X. R.; Barbacid, M.; Sabe, H.; Hanafusa, H.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2777-85</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">Src homol. 2 (SH2) domains provide specificity to intracellular signaling by binding to specific phosphotyrosine (phospho-Tyr)-contg. sequences.  The authors recently developed a technique using a degenerate phosphopeptide library to predict the specificity of individual SH2 domains src family members, Abl, Nck, Sem5, phospholipase C-Î³, p85 subunit of phosphatidylinositol-3-kinase, and SHPTP2 (Z. Songyang, S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. M. Chou, H. Hanafusa, B. Schaffhausen, and L. C. Cantley, Cell, 72:767-778, 1993).  The authors report here the optimal recognition motifs for SH2 domains from GRB-2, Drk, Csk, Vav, fps/fes, SHC, Syk (carboxy-terminal SH2), 3BP2, and HCP (amino-terminal SH2 domain, also called PTP1C and SHPTP1).  As predicted, SH2 domains from proteins that fall into group I on the basis of a Phe or Tyr at the Î²D5 position (GRB-2, 3BP2, Csk, fps/fes, Syk C-terminal SH2) select phosphopeptides with the general motif phospho-Tyr-hydrophilic (residue)-hydrophilic (residue)-hydrophobic (residue).  The SH2 domains of SHC and HCP (group III proteins with Ile, Leu, or Cys at the Î²D5 position) selected the general motif phospho-Tyr-hydrophobic-Xxx-hydrophobic, also as predicted.  Vav, which has a Thr at the Î²D5 position, selected phospho-Tyr-Met-Glu-Pro as the optimal motif.  Each SH2 domain selected a unique optimal motif distinct from motifs previously detd. for other SH2 domains.  These motifs are used to predict potential sites in signaling proteins for interaction with specific SH2 domain-contg. proteins.  The Syk SH2 domain is predicted to bind to Tyr-hydrophilic-hydrophilic-Leu/Ile motifs like those repeated at 10-residue intervals in T- and B-cell receptor-assocd. proteins.  SHC is predicted to bind to a subgroup of these same motifs.  A structural basis for the assocn. of Csk with Src family members is also suggested from these studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDwa25r4DEDbVg90H21EOLACvtfcHk0liIwFuGzkYMEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXktVenur8%253D&md5=51bfdaf8c43a4b01c39011f79930e85c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FMCB.14.4.2777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.14.4.2777%26sid%3Dliteratum%253Aachs%26aulast%3DSongyang%26aufirst%3DZ.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26aulast%3DMcGlade%26aufirst%3DJ.%26aulast%3DOlivier%26aufirst%3DP.%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DBustelo%26aufirst%3DX.%2BR.%26aulast%3DBarbacid%26aufirst%3DM.%26aulast%3DSabe%26aufirst%3DH.%26aulast%3DHanafusa%26aufirst%3DH.%26aulast%3DYi%26aufirst%3DT.%26atitle%3DSpecific%2520motifs%2520recognized%2520by%2520the%2520SH2%2520domains%2520of%2520Csk%252C%25203BP2%252C%2520fps%252Ffes%252C%2520GRB-2%252C%2520HCP%252C%2520SHC%252C%2520Syk%252C%2520and%2520Vav%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1994%26volume%3D14%26spage%3D2777%26epage%3D2785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Tari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Berestein, G.</span><span> </span><span class="NLM_article-title">GRB2: A pivotal protein in signal transduction</span> <span class="citation_source-journal">Semin. Oncol.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">28</span> <span class="NLM_fpage">142</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1016%2FS0093-7754%2801%2990291-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=11706405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpt1Wnsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=142-147&author=A.+M.+Tariauthor=G.+Lopez-Berestein&title=GRB2%3A+A+pivotal+protein+in+signal+transduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">GRB2: A pivotal protein in signal transduction</span></div><div class="casAuthors">Tari, Ana M.; Lopez-Berestein, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5, Suppl. 16</span>),
    <span class="NLM_cas:pages">142-147</span>CODEN:
                <span class="NLM_cas:coden">SOLGAV</span>;
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">A review.  The growth factor receptor-bound protein-2 (GRB2) is essential for multiple cellular functions.  Inhibition of GRB2 function impairs developmental processes in various organisms and blocks transformation and proliferation of various cell types.  GRB2 is most well known for its ability to link the epidermal growth factor receptor tyrosine kinase to the activation of RAS and its downstream kinases, ERK1,2.  We recently reported that GRB2 does not link the HER2 tyrosine kinase to the activation of ERK1,2 but to another kinase, AKT.  So, different tyrosine kinases may converge on GRB2 for signaling; however, they may not always use GRB2 to effect the same downstream kinases for cellular functions.  It is likely that GRB2 will be found to regulate many more kinases because it plays such a pivotal role in signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_ZWTibbVlXLVg90H21EOLACvtfcHk0liIwFuGzkYMEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpt1Wnsrs%253D&md5=50c9bba406a8f6c14542860a712e2834</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0093-7754%2801%2990291-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0093-7754%252801%252990291-X%26sid%3Dliteratum%253Aachs%26aulast%3DTari%26aufirst%3DA.%2BM.%26aulast%3DLopez-Berestein%26aufirst%3DG.%26atitle%3DGRB2%253A%2520A%2520pivotal%2520protein%2520in%2520signal%2520transduction%26jtitle%3DSemin.%2520Oncol.%26date%3D2001%26volume%3D28%26spage%3D142%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gururaj, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, C. J.</span><span> </span><span class="NLM_article-title">p21-activated kinases in cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">459</span> <span class="NLM_lpage">471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1038%2Fnrc1892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=16723992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvVylt70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=459-471&author=R.+Kumarauthor=A.+E.+Gururajauthor=C.+J.+Barnes&title=p21-activated+kinases+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">p21-activated kinases in cancer</span></div><div class="casAuthors">Kumar, Rakesh; Gururaj, Anupama E.; Barnes, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">459-471</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The pivotal role of kinases in signal transduction and cellular regulation has lent them considerable appeal as pharmacol. targets across a broad spectrum of cancers. p21-activated kinases (Paks) are serine/threonine kinases that function as downstream nodes for various oncogenic signaling pathways.  Paks are well-known regulators of cytoskeletal remodelling and cell motility, but have recently also been shown to promote cell proliferation, regulate apoptosis and accelerate mitotic abnormalities, which results in tumor formation and cell invasiveness.  Alterations in Pak expression have been detected in human tumors, which makes them an attractive new therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEHHgDDNNCdrVg90H21EOLACvtfcHk0liIwFuGzkYMEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvVylt70%253D&md5=d802d2c4dfe3c2fe7846ce643192e46e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrc1892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1892%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DGururaj%26aufirst%3DA.%2BE.%26aulast%3DBarnes%26aufirst%3DC.%2BJ.%26atitle%3Dp21-activated%2520kinases%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D459%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Schlaepfer, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Geer, P.</span><span> </span><span class="NLM_article-title">Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase</span> <span class="citation_source-journal">Nature</span><span class="NLM_year" style="font-weight: bold;">1994</span> <span class="NLM_volume">372</span> <span class="NLM_fpage">786</span> <span class="NLM_lpage">791</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=1994&pages=786-791&author=D.+D.+Schlaepferauthor=S.+K.+Hanksauthor=T.+Hunterauthor=P.+Van+der+Geer&title=Integrin-mediated+signal+transduction+linked+to+Ras+pathway+by+GRB2+binding+to+focal+adhesion+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchlaepfer%26aufirst%3DD.%2BD.%26aulast%3DHanks%26aufirst%3DS.%2BK.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DVan%2Bder%2BGeer%26aufirst%3DP.%26atitle%3DIntegrin-mediated%2520signal%2520transduction%2520linked%2520to%2520Ras%2520pathway%2520by%2520GRB2%2520binding%2520to%2520focal%2520adhesion%2520kinase%26jtitle%3DNature%26date%3D1994%26volume%3D372%26spage%3D786%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Mitra, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikolon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsia, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard-Trifilo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupack, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheresh, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlaepfer, D. D.</span><span> </span><span class="NLM_article-title">Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">25</span> <span class="NLM_fpage">5969</span> <span class="NLM_lpage">5984</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=5969-5984&author=S.+K.+Mitraauthor=D.+Mikolonauthor=J.+E.+Molinaauthor=D.+A.+Hsiaauthor=D.+A.+Hansonauthor=A.+Chiauthor=S.+T.+Limauthor=J.+A.+Bernard-Trifiloauthor=D.+Ilicauthor=D.+G.+Stupackauthor=D.+A.+Chereshauthor=D.+D.+Schlaepfer&title=Intrinsic+FAK+activity+and+Y925+phosphorylation+facilitate+an+angiogenic+switch+in+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMitra%26aufirst%3DS.%2BK.%26aulast%3DMikolon%26aufirst%3DD.%26aulast%3DMolina%26aufirst%3DJ.%2BE.%26aulast%3DHsia%26aufirst%3DD.%2BA.%26aulast%3DHanson%26aufirst%3DD.%2BA.%26aulast%3DChi%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DS.%2BT.%26aulast%3DBernard-Trifilo%26aufirst%3DJ.%2BA.%26aulast%3DIlic%26aufirst%3DD.%26aulast%3DStupack%26aufirst%3DD.%2BG.%26aulast%3DCheresh%26aufirst%3DD.%2BA.%26aulast%3DSchlaepfer%26aufirst%3DD.%2BD.%26atitle%3DIntrinsic%2520FAK%2520activity%2520and%2520Y925%2520phosphorylation%2520facilitate%2520an%2520angiogenic%2520switch%2520in%2520tumors%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26spage%3D5969%26epage%3D5984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">McLean, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carragher, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avizienyte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunton, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frame, M. C.</span><span> </span><span class="NLM_article-title">The role of focal-adhesion kinase in cancerâa new therapeutic opportunity</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">505</span> <span class="NLM_lpage">515</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1038%2Fnrc1647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=16069815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtFOns7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=505-515&author=G.+W.+McLeanauthor=N.+O.+Carragherauthor=E.+Avizienyteauthor=J.+Evansauthor=V.+G.+Bruntonauthor=M.+C.+Frame&title=The+role+of+focal-adhesion+kinase+in+cancer%E2%80%94a+new+therapeutic+opportunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The role of focal-adhesion kinase in cancer - A new therapeutic opportunity</span></div><div class="casAuthors">McLean, Gordon W.; Carragher, Neil O.; Avizienyte, Egle; Evans, Jeff; Brunton, Valerie G.; Frame, Margaret C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">505-515</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  I Focal-adhesion kinase (FAK) is an important mediator of growth-factor signaling, cell proliferation, cell survival and cell migration.  Given that the development of malignancy is often assocd. with perturbations in these processes, it is not surprising that FAK activity is altered in cancer cells.  Mouse models have shown that FAK is involved in tumor formation and progression, and other studies showing that FAK expression is increased in human tumors make FAK a potentially important new therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplqluP90LTaLVg90H21EOLACvtfcHk0lgHCE8yJmvT6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtFOns7k%253D&md5=805ddeb142a8d73e111cf8211dbcdfa9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrc1647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1647%26sid%3Dliteratum%253Aachs%26aulast%3DMcLean%26aufirst%3DG.%2BW.%26aulast%3DCarragher%26aufirst%3DN.%2BO.%26aulast%3DAvizienyte%26aufirst%3DE.%26aulast%3DEvans%26aufirst%3DJ.%26aulast%3DBrunton%26aufirst%3DV.%2BG.%26aulast%3DFrame%26aufirst%3DM.%2BC.%26atitle%3DThe%2520role%2520of%2520focal-adhesion%2520kinase%2520in%2520cancer%25E2%2580%2594a%2520new%2520therapeutic%2520opportunity%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D505%26epage%3D515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Dharmawardana, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peruzzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giubellino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottaro, D. P.</span><span> </span><span class="NLM_article-title">Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategy</span> <span class="citation_source-journal">Anti-Cancer Drugs</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">17</span> <span class="NLM_fpage">13</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=13-20&author=P.+G.+Dharmawardanaauthor=B.+Peruzziauthor=A.+Giubellinoauthor=J.+Burkeauthor=D.+P.+Bottaro&title=Molecular+targeting+of+growth+factor+receptor-bound+2+%28Grb2%29+as+an+anti-cancer+strategy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDharmawardana%26aufirst%3DP.%2BG.%26aulast%3DPeruzzi%26aufirst%3DB.%26aulast%3DGiubellino%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DJ.%26aulast%3DBottaro%26aufirst%3DD.%2BP.%26atitle%3DMolecular%2520targeting%2520of%2520growth%2520factor%2520receptor-bound%25202%2520%2528Grb2%2529%2520as%2520an%2520anti-cancer%2520strategy%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2006%26volume%3D17%26spage%3D13%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Burke, T. R.</span><span> </span><span class="NLM_article-title">Development of Grb2 SH2 domain signaling antagonists: a potential new class of antiproliferative agents</span> <span class="citation_source-journal">Int. J. Pept. Res. Ther.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">33</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1007%2Fs10989-006-9014-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=19444322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVKlu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=33-48&author=T.+R.+Burke&title=Development+of+Grb2+SH2+domain+signaling+antagonists%3A+a+potential+new+class+of+antiproliferative+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Grb2 SH2 domain signaling antagonists: a potential new class of antiproliferative agents</span></div><div class="casAuthors">Burke, Terrence R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Peptide Research and Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-48</span>CODEN:
                <span class="NLM_cas:coden">IJPRFC</span>;
        ISSN:<span class="NLM_cas:issn">1573-3149</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Aberrant signaling through protein-tyrosine kinase (PTK)-dependent pathways is assocd. with several proliferative diseases.  Accordingly, PTK inhibitors are being developed as new approaches for the treatment of certain cancers.  Growth factor receptor bound protein 2 (Grb2) is an important downstream mediator of PTK signaling that serves obligatory roles in many pathogenic processes.  One of the primary functions of Grb2 is to bind to specific phosphotyrosyl (pTyr)-contg. sequences through its Src homol. 2 (SH2) domain.  Agents that bind to the Grb2 SH2 domain and prevent its normal function could disrupt assocd. PTK signaling and serve as alternatives to kinase-directed inhibitors.  Starting from the x-ray crystal structure of a lead peptide bound to the Grb2 SH2 domain, this review will summarize important contributions to these efforts.  The presentation will be thematically arranged according to the region of peptide modified, proceeding from the N-terminus to the C-terminus, with a special section devoted to aspects of conformational constraint.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpT5-KbxzDDrVg90H21EOLACvtfcHk0lgHCE8yJmvT6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVKlu7o%253D&md5=b7fd41f32b1ba0f9028e34548076c0c1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs10989-006-9014-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10989-006-9014-7%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DDevelopment%2520of%2520Grb2%2520SH2%2520domain%2520signaling%2520antagonists%253A%2520a%2520potential%2520new%2520class%2520of%2520antiproliferative%2520agents%26jtitle%3DInt.%2520J.%2520Pept.%2520Res.%2520Ther.%26date%3D2006%26volume%3D12%26spage%3D33%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Atabey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breckenridge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottaro, D. P.</span><span> </span><span class="NLM_article-title">Potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion and branching morphogenesis by antagonists of Grb2 Src homology 2 domain interactions</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">276</span> <span class="NLM_fpage">14308</span> <span class="NLM_lpage">14314</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=14308-14314&author=N.+Atabeyauthor=Y.+Gaoauthor=Z.+J.+Yaoauthor=D.+Breckenridgeauthor=L.+Soonauthor=J.+V.+Sorianoauthor=T.+R.+Burkeauthor=D.+P.+Bottaro&title=Potent+blockade+of+hepatocyte+growth+factor-stimulated+cell+motility%2C+matrix+invasion+and+branching+morphogenesis+by+antagonists+of+Grb2+Src+homology+2+domain+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtabey%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DZ.%2BJ.%26aulast%3DBreckenridge%26aufirst%3DD.%26aulast%3DSoon%26aufirst%3DL.%26aulast%3DSoriano%26aufirst%3DJ.%2BV.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DBottaro%26aufirst%3DD.%2BP.%26atitle%3DPotent%2520blockade%2520of%2520hepatocyte%2520growth%2520factor-stimulated%2520cell%2520motility%252C%2520matrix%2520invasion%2520and%2520branching%2520morphogenesis%2520by%2520antagonists%2520of%2520Grb2%2520Src%2520homology%25202%2520domain%2520interactions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D14308%26epage%3D14314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Soriano, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underhill, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottaro, D. P.</span><span> </span><span class="NLM_article-title">Inhibition of angiogenesis by growth factor receptor bound protein 2-Src homology 2 domain binding antagonists</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">1289</span> <span class="NLM_lpage">1299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=15486196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVSrs7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1289-1299&author=J.+V.+Sorianoauthor=N.+Liuauthor=Y.+Gaoauthor=Z.+Y.+Yaoauthor=T.+Ishibashiauthor=C.+Underhillauthor=T.+R.+Burkeauthor=D.+P.+Bottaro&title=Inhibition+of+angiogenesis+by+growth+factor+receptor+bound+protein+2-Src+homology+2+domain+binding+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of angiogenesis by growth factor receptor bound protein 2-Src homology 2 domain bound antagonists</span></div><div class="casAuthors">Soriano, Jesus V.; Liu, Ningfei; Gao, Yang; Yao, Zhu-Jun; Ishibashi, Toshio; Underhill, Charles; Burke, Terrence R., Jr.; Bottaro, Donald P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1289-1299</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Growth factor receptor bound protein 2 (Grb2) is an intracellular adaptor protein that participates in the signal transduction cascades of several angiogenic factors, including hepatocyte growth factor, basic fibroblast growth factor, and vascular endothelial growth factor.  We described previously the potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion, and epithelial tubulogenesis by synthetic Grb2-Src homol. 2 (SH2) domain binding antagonists.  Here, we show that these binding antagonists block basic morphogenetic events required for angiogenesis, including hepatocyte growth factor-, vascular endothelial growth factor-, and basic fibroblast growth factor-stimulated endothelial cell proliferation and migration, as well as phorbol 12-myristate 13-acetate-stimulated endothelial cell migration and matrix invasion.  The Grb2-SH2 domain binding antagonists also impair angiogenesis in vitro, as shown by the inhibition of cord formation by macrovascular endothelial cells on Matrigel.  We further show that a representative compd. inhibits angiogenesis in vivo as measured using a chick chorioallantoic membrane assay.  These results suggest that Grb2 is an important mediator of key proangiogenic events, with potential application to pathol. conditions where neovascularization contributes to disease progression.  In particular, the well-characterized role of Grb2 in signaling cell cycle progression together with our present findings suggests that Grb2-SH2 domain binding antagonists have the potential to act as anticancer drugs that target both tumor and vascular cell compartments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXp1fXrsMZY7Vg90H21EOLACvtfcHk0lhCA2h1Q7-RpA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVSrs7c%253D&md5=6de14544916e3c13f21ef44b520290d4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoriano%26aufirst%3DJ.%2BV.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DZ.%2BY.%26aulast%3DIshibashi%26aufirst%3DT.%26aulast%3DUnderhill%26aufirst%3DC.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DBottaro%26aufirst%3DD.%2BP.%26atitle%3DInhibition%2520of%2520angiogenesis%2520by%2520growth%2520factor%2520receptor%2520bound%2520protein%25202-Src%2520homology%25202%2520domain%2520binding%2520antagonists%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D1289%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Giubellino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasselli, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medepalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepel, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottaro, D. P.</span><span> </span><span class="NLM_article-title">Inhibition of tumor metastasis by a growth factor receptor bound protein 2 Src homology 2 domain-binding antagonist</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">67</span> <span class="NLM_fpage">6012</span> <span class="NLM_lpage">6016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=6012-6016&author=A.+Giubellinoauthor=Y.+Gaoauthor=S.+Leeauthor=M.+J.+Leeauthor=J.+R.+Vasselliauthor=S.+Medepalliauthor=J.+B.+Trepelauthor=T.+R.+Burkeauthor=D.+P.+Bottaro&title=Inhibition+of+tumor+metastasis+by+a+growth+factor+receptor+bound+protein+2+Src+homology+2+domain-binding+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiubellino%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DVasselli%26aufirst%3DJ.%2BR.%26aulast%3DMedepalli%26aufirst%3DS.%26aulast%3DTrepel%26aufirst%3DJ.%2BB.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DBottaro%26aufirst%3DD.%2BP.%26atitle%3DInhibition%2520of%2520tumor%2520metastasis%2520by%2520a%2520growth%2520factor%2520receptor%2520bound%2520protein%25202%2520Src%2520homology%25202%2520domain-binding%2520antagonist%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D6012%26epage%3D6016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Shi, Z. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worthy, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bindu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.</span><span> </span><span class="NLM_article-title">Synthesis of a C-terminally biotinylated macrocyclic peptide mimetic exhibiting high Grb2 SH2 domain-binding affinity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">4200</span> <span class="NLM_lpage">4208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=4200-4208&author=Z.+D.+Shiauthor=H.+Liuauthor=M.+Zhangauthor=K.+M.+Worthyauthor=L.+Binduauthor=D.+Yangauthor=R.+J.+Fisherauthor=T.+R.+Burke&title=Synthesis+of+a+C-terminally+biotinylated+macrocyclic+peptide+mimetic+exhibiting+high+Grb2+SH2+domain-binding+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DZ.%2BD.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DWorthy%26aufirst%3DK.%2BM.%26aulast%3DBindu%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DFisher%26aufirst%3DR.%2BJ.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DSynthesis%2520of%2520a%2520C-terminally%2520biotinylated%2520macrocyclic%2520peptide%2520mimetic%2520exhibiting%2520high%2520Grb2%2520SH2%2520domain-binding%2520affinity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D4200%26epage%3D4208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Sasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuki, T.</span><span> </span><span class="NLM_article-title">Rational design of Mn-salen catalyst (2): highly enantioselective epoxidation of conjugated cis-olefins</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_year" style="font-weight: bold;">1994</span> <span class="NLM_volume">50</span> <span class="NLM_fpage">11827</span> <span class="NLM_lpage">11838</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=11827-11838&author=H.+Sasakiauthor=R.+Irieauthor=T.+Hamadaauthor=K.+Suzukiauthor=T.+Katsuki&title=Rational+design+of+Mn-salen+catalyst+%282%29%3A+highly+enantioselective+epoxidation+of+conjugated+cis-olefins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DIrie%26aufirst%3DR.%26aulast%3DHamada%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DKatsuki%26aufirst%3DT.%26atitle%3DRational%2520design%2520of%2520Mn-salen%2520catalyst%2520%25282%2529%253A%2520highly%2520enantioselective%2520epoxidation%2520of%2520conjugated%2520cis-olefins%26jtitle%3DTetrahedron%26date%3D1994%26volume%3D50%26spage%3D11827%26epage%3D11838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Cabri, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candiani, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedeschi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santi, R.</span><span> </span><span class="NLM_article-title">1,10-Phenanthroline derivatives: a new ligand class in the Heck reaction. Mechanistic aspects</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_year" style="font-weight: bold;">1993</span> <span class="NLM_volume">58</span> <span class="NLM_fpage">7421</span> <span class="NLM_lpage">7426</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00078a021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=7421-7426&author=W.+Cabriauthor=I.+Candianiauthor=A.+Bedeschiauthor=R.+Santi&title=1%2C10-Phenanthroline+derivatives%3A+a+new+ligand+class+in+the+Heck+reaction.+Mechanistic+aspects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjo00078a021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00078a021%26sid%3Dliteratum%253Aachs%26aulast%3DCabri%26aufirst%3DW.%26aulast%3DCandiani%26aufirst%3DI.%26aulast%3DBedeschi%26aufirst%3DA.%26aulast%3DSanti%26aufirst%3DR.%26atitle%3D1%252C10-Phenanthroline%2520derivatives%253A%2520a%2520new%2520ligand%2520class%2520in%2520the%2520Heck%2520reaction.%2520Mechanistic%2520aspects%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1993%26volume%3D58%26spage%3D7421%26epage%3D7426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.</span><span> </span><span class="NLM_article-title">Stereoselective preparation of <span class="smallcaps smallerCapital">l</span>-4-(2â²-malonyl)phenylalanine suitably protected for Fmoc-based synthesis of potent signal transduction inhibitory ligands</span> <span class="citation_source-journal">Synlett</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_fpage">134</span> <span class="NLM_lpage">136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=134-136&author=Y.+Gaoauthor=T.+R.+Burke&title=Stereoselective+preparation+of+l-4-%282%E2%80%B2-malonyl%29phenylalanine+suitably+protected+for+Fmoc-based+synthesis+of+potent+signal+transduction+inhibitory+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DStereoselective%2520preparation%2520of%2520l-4-%25282%25E2%2580%25B2-malonyl%2529phenylalanine%2520suitably%2520protected%2520for%2520Fmoc-based%2520synthesis%2520of%2520potent%2520signal%2520transduction%2520inhibitory%2520ligands%26jtitle%3DSynlett%26date%3D2000%26spage%3D134%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Mikol, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurini, M. G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hommel, U.</span><span> </span><span class="NLM_article-title">Crystal structure of the SH2 domain from the adaptor protein SHC: a model for peptide binding based on X-ray and NMR data</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">254</span> <span class="NLM_fpage">86</span> <span class="NLM_lpage">95</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=1995&pages=86-95&author=V.+Mikolauthor=G.+Baumannauthor=M.+G.+M.+Zuriniauthor=U.+Hommel&title=Crystal+structure+of+the+SH2+domain+from+the+adaptor+protein+SHC%3A+a+model+for+peptide+binding+based+on+X-ray+and+NMR+data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMikol%26aufirst%3DV.%26aulast%3DBaumann%26aufirst%3DG.%26aulast%3DZurini%26aufirst%3DM.%2BG.%2BM.%26aulast%3DHommel%26aufirst%3DU.%26atitle%3DCrystal%2520structure%2520of%2520the%2520SH2%2520domain%2520from%2520the%2520adaptor%2520protein%2520SHC%253A%2520a%2520model%2520for%2520peptide%2520binding%2520based%2520on%2520X-ray%2520and%2520NMR%2520data%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D254%26spage%3D86%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karki, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Z. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worthy, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bindu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chertov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillette, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maderia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicklaus, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.</span><span> </span><span class="NLM_article-title">Evaluation of macrocyclic Grb2 SH2 domain-binding peptide mimetics prepared by ring-closing metathesis of C-terminal allylglycines with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">2431</span> <span class="NLM_lpage">2438</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=2431-2438&author=S.+Oishiauthor=R.+G.+Karkiauthor=Z.+D.+Shiauthor=K.+M.+Worthyauthor=L.+Binduauthor=O.+Chertovauthor=D.+Espositoauthor=P.+Frankauthor=W.+K.+Gilletteauthor=M.+Maderiaauthor=J.+Hartleyauthor=M.+C.+Nicklausauthor=J.+Barchiauthor=R.+J.+Fisherauthor=T.+R.+Burke&title=Evaluation+of+macrocyclic+Grb2+SH2+domain-binding+peptide+mimetics+prepared+by+ring-closing+metathesis+of+C-terminal+allylglycines+with+an+N-terminal+beta-vinyl-substituted+phosphotyrosyl+mimetic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DKarki%26aufirst%3DR.%2BG.%26aulast%3DShi%26aufirst%3DZ.%2BD.%26aulast%3DWorthy%26aufirst%3DK.%2BM.%26aulast%3DBindu%26aufirst%3DL.%26aulast%3DChertov%26aufirst%3DO.%26aulast%3DEsposito%26aufirst%3DD.%26aulast%3DFrank%26aufirst%3DP.%26aulast%3DGillette%26aufirst%3DW.%2BK.%26aulast%3DMaderia%26aufirst%3DM.%26aulast%3DHartley%26aufirst%3DJ.%26aulast%3DNicklaus%26aufirst%3DM.%2BC.%26aulast%3DBarchi%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DR.%2BJ.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DEvaluation%2520of%2520macrocyclic%2520Grb2%2520SH2%2520domain-binding%2520peptide%2520mimetics%2520prepared%2520by%2520ring-closing%2520metathesis%2520of%2520C-terminal%2520allylglycines%2520with%2520an%2520N-terminal%2520beta-vinyl-substituted%2520phosphotyrosyl%2520mimetic%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D2431%26epage%3D2438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Puto, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pestonjamasp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bokoch, G. M.</span><span> </span><span class="NLM_article-title">p21-activated kinase 1 (PAK1) interacts with the Grb2 adapter protein to couple to growth factor signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">278</span> <span class="NLM_fpage">9388</span> <span class="NLM_lpage">9393</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=9388-9393&author=L.+A.+Putoauthor=K.+Pestonjamaspauthor=C.+C.+Kingauthor=G.+M.+Bokoch&title=p21-activated+kinase+1+%28PAK1%29+interacts+with+the+Grb2+adapter+protein+to+couple+to+growth+factor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuto%26aufirst%3DL.%2BA.%26aulast%3DPestonjamasp%26aufirst%3DK.%26aulast%3DKing%26aufirst%3DC.%2BC.%26aulast%3DBokoch%26aufirst%3DG.%2BM.%26atitle%3Dp21-activated%2520kinase%25201%2520%2528PAK1%2529%2520interacts%2520with%2520the%2520Grb2%2520adapter%2520protein%2520to%2520couple%2520to%2520growth%2520factor%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D9388%26epage%3D9393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Singh, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span> </span><span class="NLM_article-title">Nuclear localization and chromatin targets of p21-activated kinase 1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">280</span> <span class="NLM_fpage">18130</span> <span class="NLM_lpage">18137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=18130-18137&author=R.+R.+Singhauthor=C.+Songauthor=Z.+Yangauthor=R.+Kumar&title=Nuclear+localization+and+chromatin+targets+of+p21-activated+kinase+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DR.%2BR.%26aulast%3DSong%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DKumar%26aufirst%3DR.%26atitle%3DNuclear%2520localization%2520and%2520chromatin%2520targets%2520of%2520p21-activated%2520kinase%25201%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D18130%26epage%3D18137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">OâSullivan, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tangney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrose, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, O. P.</span><span> </span><span class="NLM_article-title">Modulation of p21-activated kinase 1 alters the behavior of renal cell carcinoma</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">121</span> <span class="NLM_fpage">1930</span> <span class="NLM_lpage">1940</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1002%2Fijc.22893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=17621631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSjsL7F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2007&pages=1930-1940&author=G.+C.+O%E2%80%99Sullivanauthor=M.+Tangneyauthor=G.+Caseyauthor=M.+Ambroseauthor=A.+Houstonauthor=O.+P.+Barry&title=Modulation+of+p21-activated+kinase+1+alters+the+behavior+of+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of p21-activated kinase 1 alters the behavior of renal cell carcinoma</span></div><div class="casAuthors">O'Sullivan, Gerald C.; Tangney, Mark; Casey, Garret; Ambrose, Monica; Houston, Aileen; Barry, Orla P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1930-1940</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The p21-activated kinase 1 (Pak1) is a serine/threonine kinase whose activity is regulated by both Rho GTPases and AGC kinase family members.  It plays a role in cytoskeletal remodeling and cell motility as well as cell proliferation, angiogenesis, tumorigenesis and metastasis.  An involvement of Pak1 in renal cell carcinoma (RCC), which remains highly refractory to chemotherapy and radiotherapy, remains to be investigated.  Pak1 expression, phosphorylation and kinase activity were examd. in RCC cell lines and human tissue from normal and renal carcinoma.  We report increased Pak1 expression and constitutive activity in the membrane and nucleus but not the cytoplasm of resected human RCC.  To study a role for Pak1 in RCC, we developed 786-0 clones that expressed either a kinase-active Pak1L83,L86 2 different Pak1 dominant neg. mutants, Pak1R299 and Pak1L83,L86,R299 or Pak1 siRNA.  The expression of Pak1L83,L86 increased 786-0 proliferation, motility and anchorage independent growth, while the dominant neg. mutants and Pak1 siRNA abrogated these effects.  In addn., Pak1L83,L86 conferred resistance to 5-fluorouracil with a 40% Â± 10% increase in cell viability.  Conversely, Pak1L83,L86,R299, Pak1R299 and Pak1 siRNA conferred sensitivity with a 65.2% Â± 5.5%, 69.2% Â± 3.3% and 73.0% Â± 8.4% loss in viability, resp.  Finally, Pak1 plays a role in renal tumor growth in vivo.  Only 33% of mice developed tumors in the Pak1L83,L86,R299 group and no tumors developed from Pak1R299 cell challenge.  Together these findings point to Pak1 as an exciting target for therapy of renal cancer, which remains highly refractory to existing treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8oLNZaOV7gbVg90H21EOLACvtfcHk0li326Qz_MPYPw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSjsL7F&md5=bed92eb73dda915c5a19af8e5b988b1e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fijc.22893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22893%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DG.%2BC.%26aulast%3DTangney%26aufirst%3DM.%26aulast%3DCasey%26aufirst%3DG.%26aulast%3DAmbrose%26aufirst%3DM.%26aulast%3DHouston%26aufirst%3DA.%26aulast%3DBarry%26aufirst%3DO.%2BP.%26atitle%3DModulation%2520of%2520p21-activated%2520kinase%25201%2520alters%2520the%2520behavior%2520of%2520renal%2520cell%2520carcinoma%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D121%26spage%3D1930%26epage%3D1940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Rayala, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span> </span><span class="NLM_article-title">Sliding p21-activated kinase 1 to nucleus impacts tamoxifen sensitivity</span> <span class="citation_source-journal">Biomed. Pharmacother.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">61</span> <span class="NLM_fpage">408</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1016%2Fj.biopha.2007.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=17604944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1Crsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=408-411&author=S.+K.+Rayalaauthor=R.+Kumar&title=Sliding+p21-activated+kinase+1+to+nucleus+impacts+tamoxifen+sensitivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Sliding p21-activated kinase 1 to nucleus impacts tamoxifen sensitivity</span></div><div class="casAuthors">Rayala, Suresh K.; Kumar, Rakesh</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">408-411</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  The anti-estrogen, tamoxifen is the most commonly used treatment for patients with estrogen receptor (ER)-alpha-pos. breast cancer.  Recent data suggest that levels of ER coregulatory proteins as well as extra- and intracellular signaling in response to growth factor stimulation of breast cancer cells play an important role in acquiring resistance to anti-estrogen action.  P21-activated kinase 1 (PAK1), a major target of the small GTPases, growth factors and lipid signaling, regulates cell motility, hormone action, invasiveness, and survival, all of which are required for both tumor development and normal mammary gland development.  Over the years, the PAK1 has been regarded as cytosolic serine-threonine kinase with regulatory function in cytoskeleton reorganization and motility.  However, emerging data now provide evidence of PAK1 function in the nucleus of breast cancer cells.  Elevated PAK1 expression in premenopausal breast cancer patients correlates well with the lack of tamoxifen response despite the presence of ER-alpha expression, and such relationship was even distinctly stronger in breast tumors with nuclear PAK1.  These typical effects of PAK1 are mechanistically linked with the ability of PAK1 to phosphorylate ER-alpha on serine 305, accompanied by secondary activation of serine 118, and such structural modifications may participate in the development of tamoxifen resistance.  These findings suggest that the levels, subcellular localization, and activation status of PAK1 are likely to be important determinants of tamoxifen resistance, and that raising the possibility that tamoxifen resistance might be prevented or reversed by PAK1 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohquj1oKutCLVg90H21EOLACvtfcHk0lgrP6lPDV0aMg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1Crsbs%253D&md5=df694385f4dd7892d62d23c921b6da97</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2007.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2007.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DRayala%26aufirst%3DS.%2BK.%26aulast%3DKumar%26aufirst%3DR.%26atitle%3DSliding%2520p21-activated%2520kinase%25201%2520to%2520nucleus%2520impacts%2520tamoxifen%2520sensitivity%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2007%26volume%3D61%26spage%3D408%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Machida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, B. J.</span><span> </span><span class="NLM_article-title">The SH2 domain: versatile signaling module and pharmaceutical target</span> <span class="citation_source-journal">Biochim. Biophys. Actaica et Biophysica Acta, Proteins Proteomics</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">1747</span> <span class="NLM_fpage">1</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1016%2Fj.bbapap.2004.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=15680235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFyjsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1747&publication_year=2005&pages=1-25&author=K.+Machidaauthor=B.+J.+Mayer&title=The+SH2+domain%3A+versatile+signaling+module+and+pharmaceutical+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The SH2 domain: versatile signaling module and pharmaceutical target</span></div><div class="casAuthors">Machida, Kazuya; Mayer, Bruce J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1747</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-25</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Src homol. 2 (SH2) domain is the most prevalent protein binding module that recognizes phosphotyrosine.  This â¼100-amino-acid domain is highly conserved structurally despite being found in a wide variety proteins.  Depending on the nature of neighboring protein module(s), such as catalytic domains and other protein binding domains, SH2-contg. proteins play many different roles in cellular protein tyrosine kinase (PTK) signaling pathways.  Accumulating evidence indicates that SH2 domains are highly versatile and exhibit considerable flexibility in how they bind to their ligands.  To illustrate this functional versatility, the authors present 3 specific examples: the SAP, Cbl, and SOCS families of SH2-contg. proteins, which play key roles in immune responses, termination of PTK signaling, and cytokine responses.  In addn., the authors highlight current progress in the development of SH2 domain inhibitors designed to antagonize or modulate PTK signaling in human disease.  Inhibitors of the Grb2 and Src SH2 domains have been extensively studied, with the aim of targeting the Ras pathway and osteoclastic bone resorption, resp.  Despite formidable difficulties in drug design due to the lability and poor cell permeability of neg. charged phosphorylated SH2 ligands, a variety of structure-based strategies have been used to reduce the size, charge, and peptide character of such ligands, leading to the development of high-affinity lead compds. with potent cellular activities.  These studies have also led to new insights into mol. recognition by the SH2 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh0HmXIxaUZbVg90H21EOLACvtfcHk0lgrP6lPDV0aMg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFyjsQ%253D%253D&md5=9cb0f80f5533c18251abc2cfe54760a9</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2004.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2004.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DMachida%26aufirst%3DK.%26aulast%3DMayer%26aufirst%3DB.%2BJ.%26atitle%3DThe%2520SH2%2520domain%253A%2520versatile%2520signaling%2520module%2520and%2520pharmaceutical%2520target%26jtitle%3DBiochim.%2520Biophys.%2520Actaica%2520et%2520Biophysica%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2005%26volume%3D1747%26spage%3D1%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Songyang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gish, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haser, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnofsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechleider, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birge, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fajardo, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanafusa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhausen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">SH2 domains recognize specific phosphopeptide sequences</span> <span class="citation_source-journal">Cell</span><span class="NLM_year" style="font-weight: bold;">1993</span> <span class="NLM_volume">72</span> <span class="NLM_fpage">767</span> <span class="NLM_lpage">778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1993&pages=767-778&author=Z.+Songyangauthor=S.+E.+Shoelsonauthor=M.+Chaudhuriauthor=G.+Gishauthor=T.+Pawsonauthor=W.+G.+Haserauthor=F.+Kingauthor=T.+Robertsauthor=S.+Ratnofskyauthor=R.+J.+Lechleiderauthor=B.+G.+Neelauthor=R.+B.+Birgeauthor=J.+E.+Fajardoauthor=M.+M.+Chouauthor=H.+Hanafusaauthor=B.+Schaffhausenauthor=L.+C.+Cantley&title=SH2+domains+recognize+specific+phosphopeptide+sequences"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSongyang%26aufirst%3DZ.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26aulast%3DChaudhuri%26aufirst%3DM.%26aulast%3DGish%26aufirst%3DG.%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DHaser%26aufirst%3DW.%2BG.%26aulast%3DKing%26aufirst%3DF.%26aulast%3DRoberts%26aufirst%3DT.%26aulast%3DRatnofsky%26aufirst%3DS.%26aulast%3DLechleider%26aufirst%3DR.%2BJ.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DBirge%26aufirst%3DR.%2BB.%26aulast%3DFajardo%26aufirst%3DJ.%2BE.%26aulast%3DChou%26aufirst%3DM.%2BM.%26aulast%3DHanafusa%26aufirst%3DH.%26aulast%3DSchaffhausen%26aufirst%3DB.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DSH2%2520domains%2520recognize%2520specific%2520phosphopeptide%2520sequences%26jtitle%3DCell%26date%3D1993%26volume%3D72%26spage%3D767%26epage%3D778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Z.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.</span><span> </span><span class="NLM_article-title">Inhibition of Grb2 SH2 domain binding by non-phosphate- containing ligands 2. 4-(2-Malonyl)phenylalanine as a potent phosphotyrosyl mimetic</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">43</span> <span class="NLM_fpage">911</span> <span class="NLM_lpage">920</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9904248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=911-920&author=Y.+Gaoauthor=J.+Luoauthor=Z.-J.+Yaoauthor=R.+Guoauthor=H.+Zouauthor=J.+Kelleyauthor=J.+H.+Voigtauthor=D.+Yangauthor=T.+R.+Burke&title=Inhibition+of+Grb2+SH2+domain+binding+by+non-phosphate-+containing+ligands+2.+4-%282-Malonyl%29phenylalanine+as+a+potent+phosphotyrosyl+mimetic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm9904248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9904248%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DZ.-J.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DKelley%26aufirst%3DJ.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DInhibition%2520of%2520Grb2%2520SH2%2520domain%2520binding%2520by%2520non-phosphate-%2520containing%2520ligands%25202.%25204-%25282-Malonyl%2529phenylalanine%2520as%2520a%2520potent%2520phosphotyrosyl%2520mimetic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D911%26epage%3D920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Gay, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suarez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caravatti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span> </span><span class="NLM_article-title">Selective Grb2 SH2 inhibitors as anti-Ras therapy</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">83</span> <span class="NLM_fpage">235</span> <span class="NLM_lpage">241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1002%2F%28SICI%291097-0215%2819991008%2983%3A2%3C235%3A%3AAID-IJC15%3E3.0.CO%3B2-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=10471533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADyaK1MXmvVeqsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1999&pages=235-241&author=B.+Gayauthor=S.+Suarezauthor=G.+Caravattiauthor=P.+Furetauthor=T.+Meyerauthor=J.+Schoepfer&title=Selective+Grb2+SH2+inhibitors+as+anti-Ras+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Selective GRB2 SH2 inhibitors as anti-ras therapy</span></div><div class="casAuthors">Gay, Brigitte; Suarez, Stephanie; Caravatti, Giorgio; Furet, Pascal; Meyer, Thomas; Schoepfer, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-241</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Given the key role of Ras in the mitogenic signaling by receptor tyrosine kinases, several targets upstream of Ras may prove to be excellent targets for drugs in the treatment of cancer caused by oncogenic tyrosine kinases.  CGP78850 is a potent competitor of Grb2 SH2-phosphopeptide interactions.  This inhibitor has been obtained by rational drug design and is specific toward the Grb2 SH2 vs. other SH2 domains and the PTB domain of SHC in vitro.  Accordingly, CGP78850 blocks epidermal growth factor receptor (EGFR)-Grb2 and Shc-Grb2 interactions in living cells.  It also inhibits the growth of cells transformed by receptor tyrosine kinases, which transmit a proliferative signal through Grb2 to Ras, but not cells transformed by oncogenic Raf or cells that contain activating Ras mutations.  Moreover, our results demonstrate that, in cells overexpressing receptor tyrosine kinases, such as the EGFR, Grb2 SH2 inhibitors induce expression of the cell cycle inhibitors p21Waf/Cipl/CAP1 and p27Kipl and reverse transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRZqjPZf5qKrVg90H21EOLACvtfcHk0lhUuIvtDUgIDg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvVeqsrw%253D&md5=f309f57f374af52ea1c41b86822fbe60</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819991008%2983%3A2%3C235%3A%3AAID-IJC15%3E3.0.CO%3B2-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819991008%252983%253A2%253C235%253A%253AAID-IJC15%253E3.0.CO%253B2-B%26sid%3Dliteratum%253Aachs%26aulast%3DGay%26aufirst%3DB.%26aulast%3DSuarez%26aufirst%3DS.%26aulast%3DCaravatti%26aufirst%3DG.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DSchoepfer%26aufirst%3DJ.%26atitle%3DSelective%2520Grb2%2520SH2%2520inhibitors%2520as%2520anti-Ras%2520therapy%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1999%26volume%3D83%26spage%3D235%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Z. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worthy, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bindu, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.</span><span> </span><span class="NLM_article-title">Ring-closing metathesis of C-terminal allylglycine residues with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic as an approach to novel Grb2 SH2 domain-binding macrocyles</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">668</span> <span class="NLM_lpage">674</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=668-674&author=S.+Oishiauthor=Z.+D.+Shiauthor=K.+M.+Worthyauthor=L.+K.+Binduauthor=R.+J.+Fisherauthor=T.+R.+Burke&title=Ring-closing+metathesis+of+C-terminal+allylglycine+residues+with+an+N-terminal+beta-vinyl-substituted+phosphotyrosyl+mimetic+as+an+approach+to+novel+Grb2+SH2+domain-binding+macrocyles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DShi%26aufirst%3DZ.%2BD.%26aulast%3DWorthy%26aufirst%3DK.%2BM.%26aulast%3DBindu%26aufirst%3DL.%2BK.%26aulast%3DFisher%26aufirst%3DR.%2BJ.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DRing-closing%2520metathesis%2520of%2520C-terminal%2520allylglycine%2520residues%2520with%2520an%2520N-terminal%2520beta-vinyl-substituted%2520phosphotyrosyl%2520mimetic%2520as%2520an%2520approach%2520to%2520novel%2520Grb2%2520SH2%2520domain-binding%2520macrocyles%26jtitle%3DChemBioChem%26date%3D2005%26volume%3D6%26spage%3D668%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 8 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nan  Qin</span>, <span class="hlFld-ContribAuthor ">Ting  Tang</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Song  Xie</span>, <span class="hlFld-ContribAuthor ">Fengsong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Involvement of a TNF homologue in balancing the host immune system of Macrobrachium nipponense. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2019,</strong> <em>134 </em>, 73-79. <a href="https://doi.org/10.1016/j.ijbiomac.2019.05.045" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2019.05.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2019.05.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2019.05.045%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DInvolvement%252Bof%252Ba%252BTNF%252Bhomologue%252Bin%252Bbalancing%252Bthe%252Bhost%252Bimmune%252Bsystem%252Bof%252BMacrobrachium%252Bnipponense%26aulast%3DQin%26aufirst%3DNan%26date%3D2019%26volume%3D134%26spage%3D73%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  He</span>, <span class="hlFld-ContribAuthor ">Saranyaraajan  Varadarajan</span>, <span class="hlFld-ContribAuthor ">RaÃºl  MuÃ±oz-Planillo</span>, <span class="hlFld-ContribAuthor ">Aaron  Burberry</span>, <span class="hlFld-ContribAuthor ">Yuumi  Nakamura</span>, <span class="hlFld-ContribAuthor ">Gabriel  NÃºÃ±ez</span>. </span><span class="cited-content_cbyCitation_article-title">3,4-Methylenedioxy-Î²-nitrostyrene Inhibits NLRP3 Inflammasome Activation by Blocking Assembly of the Inflammasome. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2014,</strong> <em>289 </em>
                                    (2)
                                     , 1142-1150. <a href="https://doi.org/10.1074/jbc.M113.515080" title="DOI URL">https://doi.org/10.1074/jbc.M113.515080</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M113.515080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M113.515080%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3D3%25252C4-Methylenedioxy-%2525CE%2525B2-nitrostyrene%252BInhibits%252BNLRP3%252BInflammasome%252BActivation%252Bby%252BBlocking%252BAssembly%252Bof%252Bthe%252BInflammasome%26aulast%3DHe%26aufirst%3DYuan%26date%3D2014%26volume%3D289%26issue%3D2%26spage%3D1142%26epage%3D1150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dziyana  Kraskouskaya</span>, <span class="hlFld-ContribAuthor ">Eugenia  Duodu</span>, <span class="hlFld-ContribAuthor ">Carolynn C.  Arpin</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>. </span><span class="cited-content_cbyCitation_article-title">Progress towards the development of SH2 domain inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2013,</strong> <em>42 </em>
                                    (8)
                                     , 3337. <a href="https://doi.org/10.1039/c3cs35449k" title="DOI URL">https://doi.org/10.1039/c3cs35449k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3cs35449k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3cs35449k%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DProgress%252Btowards%252Bthe%252Bdevelopment%252Bof%252BSH2%252Bdomain%252Binhibitors%26aulast%3DKraskouskaya%26aufirst%3DDziyana%26date%3D2013%26volume%3D42%26issue%3D8%26spage%3D3337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tianliang  Sun</span>, <span class="hlFld-ContribAuthor ">Rameshkumar  Krishnan</span>, <span class="hlFld-ContribAuthor ">Jakub M.  Swiercz</span>. </span><span class="cited-content_cbyCitation_article-title">Grb2 mediates semaphorin-4D-dependent RhoA inactivation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cell Science</span><span> <strong>2012,</strong> <em>125 </em>
                                    (15)
                                     , 3557-3567. <a href="https://doi.org/10.1242/jcs.101063" title="DOI URL">https://doi.org/10.1242/jcs.101063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1242/jcs.101063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1242%2Fjcs.101063%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cell%2520Science%26atitle%3DGrb2%252Bmediates%252Bsemaphorin-4D-dependent%252BRhoA%252Binactivation%26aulast%3DSun%26aufirst%3DTianliang%26date%3D2012%26volume%3D125%26issue%3D15%26spage%3D3557%26epage%3D3567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessio  Giubellino</span>. </span><span class="cited-content_cbyCitation_article-title">GRB2 Signaling as a Molecular Target for Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 1-22. <a href="https://doi.org/10.1007/978-1-4614-0730-0_1" title="DOI URL">https://doi.org/10.1007/978-1-4614-0730-0_1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4614-0730-0_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4614-0730-0_1%26sid%3Dliteratum%253Aachs%26atitle%3DGRB2%252BSignaling%252Bas%252Ba%252BMolecular%252BTarget%252Bfor%252BCancer%26aulast%3DGiubellino%26aufirst%3DAlessio%26date%3D2012%26date%3D2011%26spage%3D1%26epage%3D22%26pub%3DSpringer%2520New%2520York%26atitle%3DCell%252BSignaling%252B%252526%252BMolecular%252BTargets%252Bin%252BCancer%26aulast%3DChatterjee%26aufirst%3DMalay%26date%3D2012%26volume%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fa  Liu</span>, <span class="hlFld-ContribAuthor ">Alessio  Giubellino</span>, <span class="hlFld-ContribAuthor ">Philip C.  Simister</span>, <span class="hlFld-ContribAuthor ">Wenjian  Qian</span>, <span class="hlFld-ContribAuthor ">Michael C.  Giano</span>, <span class="hlFld-ContribAuthor ">Stephan M.  Feller</span>, <span class="hlFld-ContribAuthor ">Donald P.  Bottaro</span>, <span class="hlFld-ContribAuthor ">Terrence R.  Burke</span>. </span><span class="cited-content_cbyCitation_article-title">Application of ring-closing metathesis to Grb2 SH3 domain-binding peptides. </span><span class="cited-content_cbyCitation_journal-name">Biopolymers</span><span> <strong>2011,</strong> <em>96 </em>
                                    (6)
                                     , 780-788. <a href="https://doi.org/10.1002/bip.21692" title="DOI URL">https://doi.org/10.1002/bip.21692</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bip.21692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbip.21692%26sid%3Dliteratum%253Aachs%26jtitle%3DBiopolymers%26atitle%3DApplication%252Bof%252Bring-closing%252Bmetathesis%252Bto%252BGrb2%252BSH3%252Bdomain-binding%252Bpeptides%26aulast%3DLiu%26aufirst%3DFa%26date%3D2011%26date%3D2011%26volume%3D96%26issue%3D6%26spage%3D780%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rebecca L.  Rich</span>, <span class="hlFld-ContribAuthor ">David G.  Myszka</span>. </span><span class="cited-content_cbyCitation_article-title">Grading the commercial optical biosensor literature-Class of 2008: âThe Mighty Bindersâ. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Recognition</span><span> <strong>2010,</strong> <em>23 </em>
                                    (1)
                                     , 1-64. <a href="https://doi.org/10.1002/jmr.1004" title="DOI URL">https://doi.org/10.1002/jmr.1004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jmr.1004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjmr.1004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Recognition%26atitle%3DGrading%252Bthe%252Bcommercial%252Boptical%252Bbiosensor%252Bliterature-Class%252Bof%252B2008%25253A%252B%2525E2%252580%252598The%252BMighty%252BBinders%2525E2%252580%252599%26aulast%3DRich%26aufirst%3DRebecca%2BL.%26date%3D2010%26date%3D2009%26volume%3D23%26issue%3D1%26spage%3D1%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessio  Giubellino</span>, <span class="hlFld-ContribAuthor ">Praveen R.  Arany</span>. </span><span class="cited-content_cbyCitation_article-title">Grb2 and Other Adaptor Proteins in Tumor Metastasis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 77-102. <a href="https://doi.org/10.1007/978-90-481-9522-0_5" title="DOI URL">https://doi.org/10.1007/978-90-481-9522-0_5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-90-481-9522-0_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-90-481-9522-0_5%26sid%3Dliteratum%253Aachs%26atitle%3DGrb2%252Band%252BOther%252BAdaptor%252BProteins%252Bin%252BTumor%252BMetastasis%26aulast%3DGiubellino%26aufirst%3DAlessio%26date%3D2010%26date%3D2010%26spage%3D77%26epage%3D102%26pub%3DSpringer%2520Netherlands%26atitle%3DSignal%252BTransduction%252Bin%252BCancer%252BMetastasis%26aulast%3DWu%26aufirst%3DWen-Sheng%26date%3D2010%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/medium/jm-2008-00523u_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800523u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/medium/jm-2008-00523u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of Grb2-SH2 domain binding antagonists and analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800523u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/medium/jm-2008-00523u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0008.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Upper Segment <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800523u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions and yields: (a) Tf<sub>2</sub>NPh, 2,4,6-collidine, DMAP, DMFâCH<sub>2</sub>Cl<sub>2</sub>, reflux, 12 h, 47%; (b) Pd(OAc)<sub>2</sub>, DPPP, Et<sub>3</sub>N, reflux, 14 h, 81%; (c) LiAlH<sub>4</sub>, THF, room temp, overnight, 54%; (d) (i) Boc-Asn-OH, DIPCDI, HOBt, DMF, room temp, 12 h, 87%; (ii) TFA, CH<sub>2</sub>Cl<sub>2</sub>, room temp, 1 h, 79%; (iii) Fmoc-1-aminocyclohexenecarboxylic acid, EDC, HOBt, DMF, room temp, 12 h, 79%; (iv) piperidine, CH3CN, room temp, 2 h, 86%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/medium/jm-2008-00523u_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0009.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Inhibitor <b>2</b> and Biotinylated Ligands <b>3</b> and <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800523u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions, and yields: (a) EDC, HOBt, DMF, room temp, 12 h (79% for <b>12a</b>, 74% for <b>12b</b>); (b) (i) piperidine, CH3CN, room temp, 2 h; (ii) <i>tert</i>-butyloxalyl chloride, <sup><i>i</i></sup>Pr2NEt, DMF, room temp, 12 h (two steps, 43% for <b>13a</b>; 80% for <b>13b</b>); (c) TFAâTESâH<sub>2</sub>O, room temp, 1 h, 42%; (d) EDC, DMAP, DMF, room temp, 12 h (78% for <b>14a</b>, 42% for <b>14b</b>); (e) TFAâHS(CH<sub>2</sub>)<sub>2</sub>SHâH<sub>2</sub>O, room temp, 1 h (41% for <b>3</b>, 56% for <b>4</b>).</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/medium/jm-2008-00523u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Inhibition of cell migration by <b>1</b> and <b>3</b>. (A) Inhibition of HGF-stimulated (50 ng/mL, white bar) or unstimulated (black bar) PC3M cell migration by <b>1</b> and <b>3</b>. Values represent mean number of migrated cells per 10Ã microscopic field, expressed as percent maximum, Â±standard deviation. (B) Dose-response analysis of inhibition of PC3M cell migration by <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800523u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/medium/jm-2008-00523u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Protein capture by <b>3</b> and <b>4</b>. (A) SDSâPAGE and anti-Grb2 immunoblot analysis of lysates prepared from the human leiomyosarcoma cell line SK-LMS-1. Following target protein capture using <b>3</b> (left) or <b>4</b> (right), SA-coated beads were washed with buffer containing NaCl at the concentrations (M) indicated above each lane. (B) SDSâPAGE and immunoblot analysis of SK LMS-1 lysates (left lane) for known Grb2-associated proteins (top to bottom) Nck1, Nck2, Gab1, and Sos1 captured using <b>4</b> (middle lane) or <b>3</b> (right lane).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800523u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/medium/jm-2008-00523u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative MS/MS spectra of two [M + 2H]<sup>2+</sup> tryptic peptides from Grb2, which represent 10.1% sequence coverage, captured by <b>3</b>-conjugated beads but not <b>4</b>-conjugated beads. The b ion series is shown in red and the y ion series in blue. Sequest statistics are as follows: (A) Xcorr score = 3.707, ÎCn = 0.44, and <i>p</i> = 1.9 Ã 10<sup>â9</sup>; (B) Xcorr score = 2.98, ÎCn = 0.28, and <i>p</i> = 1.4 Ã 10<sup>â5</sup>, where Xcorr is the peptide correlation score and ÎCn is the difference in correlation between the top two peptide matches.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800523u&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/medium/jm-2008-00523u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>1</b> inhibits PAK1 activation and nuclear translocation. (A) PC3M cells were serum-deprived and treated with <b>1</b> (+, 1 Î¼M) or left untreated (â), as indicated, for 16 h, then left without further treatment (left lanes) or stimulated briefly with HGF (50 ng/mL, right lanes) for the times indicated. Cell lysates were analyzed by SDSâPAGE, and immunoblot analysis was done with anti-phospho-PAK1 antibody (upper panel) or anti-PAK1 antibody to control for protein loading (lower panel). (B) PC3M cells were treated with compound <b>1</b> for 16 h, and nuclear extracts were prepared using high-salt buffer. Samples were analyzed by SDSâPAGE, and immunoblot analysis was done with anti-PAK1 antibody (upper panel) or anti-CREB antibody (lower panel).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800523u&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/medium/jm-2008-00523u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>1</b> inhibits lamellipodia formation: Alexa 488-phalloidin (green) and DAPI staining (blue) of PC3M cells (left panels) and MDCK cells (center and right panels) treated with HGF alone (top panels, control) or HGF + <b>1</b> (1 Î¼M, lower panels). For PC3M cells, arrowheads indicate regions of cellular extension into the artificial wound. For MDCK cells, advancing lamellipodia observed in center panels are outlined in white in the right panels for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-23/jm800523u/production/images/large/jm-2008-00523u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800523u&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48520" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48520" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 28 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Blume-Jensen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span> </span><span class="NLM_article-title">Oncogenic kinase signalling</span> <span class="citation_source-journal">Nature</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">411</span> <span class="NLM_fpage">355</span> <span class="NLM_lpage">365</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1038%2F35077225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=11357143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVSjsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=355-365&author=P.+Blume-Jensenauthor=T.+Hunter&title=Oncogenic+kinase+signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic kinase signaling</span></div><div class="casAuthors">Blume-Jensen, Peter; Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">411</span>
        (<span class="NLM_cas:issue">6835</span>),
    <span class="NLM_cas:pages">355-365</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 93 refs.  Protein-tyrosine kinases (PTKs) are important regulators of intracellular signal-transduction pathways mediating development and multicellular communication in metazoans.  Their activity is normally tightly controlled and regulated.  Perturbation of PTK signaling by mutations and other genetic alterations results in deregulated kinase activity and malignant transformation.  The lipid kinase phosphoinositide 3-OH kinase (PI(3)K) and some of its downstream targets, such as the protein-serine/threonine kinases Akt and p70 S6 kinase (p70S6K), are crucial effectors in oncogenic PTK signaling.  This review emphasizes how oncogenic conversion of protein kinases results from perturbation of the normal autoinhibitory constraints on kinase activity and provides an update on our knowledge about the role of deregulated PI(3)K/Akt and mammalian target of rapamycin/p70S6K signaling in human malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJiBzQk4vjZbVg90H21EOLACvtfcHk0ligqB9C14Rexg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVSjsr0%253D&md5=cd1bce803c2daadb98cbdba8550be43b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F35077225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35077225%26sid%3Dliteratum%253Aachs%26aulast%3DBlume-Jensen%26aufirst%3DP.%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DOncogenic%2520kinase%2520signalling%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D355%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lowenstein, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batzer, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skolnik, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Sagi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span> </span><span class="NLM_article-title">The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling</span> <span class="citation_source-journal">Cell</span><span class="NLM_year" style="font-weight: bold;">1992</span> <span class="NLM_volume">70</span> <span class="NLM_fpage">431</span> <span class="NLM_lpage">442</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1016%2F0092-8674%2892%2990167-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=1322798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADyaK3sXkt1ajtbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1992&pages=431-442&author=E.+J.+Lowensteinauthor=R.+J.+Dalyauthor=A.+G.+Batzerauthor=W.+Liauthor=B.+Margolisauthor=R.+Lammersauthor=A.+Ullrichauthor=E.+Y.+Skolnikauthor=D.+Bar-Sagiauthor=J.+Schlessinger&title=The+SH2+and+SH3+domain-containing+protein+GRB2+links+receptor+tyrosine+kinases+to+ras+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling</span></div><div class="casAuthors">Lowenstein, E. J.; Daly, R. J.; Batzer, A. G.; Li, W.; Margolis, B.; Lammers, R.; Ullrich, A.; Skolnik, E. Y.; Bar-Sagi, D.; Schlessinger, J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">431-42</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">A cDNA clone encoding a novel, widely expressed protein (called growth factor receptor-bound protein 2 or GRB2) contg. one src homol. 2 (SH2) domain and two SH3 domains was isolated.  Immunoblotting expts. indicate that GRB2 assocs. with tyrosine-phosphorylated epidermal growth factor receptors (EGFRs) and platelet-derived growth factor receptors (PDGFRs) via its SH2 domain.  Interestingly, GRB2 exhibits striking structural and functional homol. to the Caenorhabditis elegans protein sem-5.  To examine whether GRB2 is also a component of ras signaling in mammalian cells, microinjection studies were performed.  While injection of GRB2 or H-ras proteins alone into quiescent rat fibroblasts did not have mitogenic effect, microinjection of GRB2 together with H-ras protein stimulated DNA synthesis.  These results suggest that GRB2/sem-5 plays a crucial role in a highly conserved mechanism for growth factor control of ras signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo0LYdxA1IuLVg90H21EOLACvtfcHk0ligqB9C14Rexg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkt1ajtbg%253D&md5=86885e1cbee3f637ae9470aa9f8c264e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2892%2990167-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252892%252990167-B%26sid%3Dliteratum%253Aachs%26aulast%3DLowenstein%26aufirst%3DE.%2BJ.%26aulast%3DDaly%26aufirst%3DR.%2BJ.%26aulast%3DBatzer%26aufirst%3DA.%2BG.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMargolis%26aufirst%3DB.%26aulast%3DLammers%26aufirst%3DR.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DSkolnik%26aufirst%3DE.%2BY.%26aulast%3DBar-Sagi%26aufirst%3DD.%26aulast%3DSchlessinger%26aufirst%3DJ.%26atitle%3DThe%2520SH2%2520and%2520SH3%2520domain-containing%2520protein%2520GRB2%2520links%2520receptor%2520tyrosine%2520kinases%2520to%2520ras%2520signaling%26jtitle%3DCell%26date%3D1992%26volume%3D70%26spage%3D431%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Songyang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGlade, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bustelo, X. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanafusa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, T.</span><span> </span><span class="NLM_article-title">Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_year" style="font-weight: bold;">1994</span> <span class="NLM_volume">14</span> <span class="NLM_fpage">2777</span> <span class="NLM_lpage">2785</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1128%2FMCB.14.4.2777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=7511210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADyaK2cXktVenur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1994&pages=2777-2785&author=Z.+Songyangauthor=S.+E.+Shoelsonauthor=J.+McGladeauthor=P.+Olivierauthor=T.+Pawsonauthor=X.+R.+Busteloauthor=M.+Barbacidauthor=H.+Sabeauthor=H.+Hanafusaauthor=T.+Yi&title=Specific+motifs+recognized+by+the+SH2+domains+of+Csk%2C+3BP2%2C+fps%2Ffes%2C+GRB-2%2C+HCP%2C+SHC%2C+Syk%2C+and+Vav"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav</span></div><div class="casAuthors">Songyang, Z.; Shoelson, S. E.; McGlade, J.; Olivier, P.; Pawson, T.; Bustelo, X. R.; Barbacid, M.; Sabe, H.; Hanafusa, H.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2777-85</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">Src homol. 2 (SH2) domains provide specificity to intracellular signaling by binding to specific phosphotyrosine (phospho-Tyr)-contg. sequences.  The authors recently developed a technique using a degenerate phosphopeptide library to predict the specificity of individual SH2 domains src family members, Abl, Nck, Sem5, phospholipase C-Î³, p85 subunit of phosphatidylinositol-3-kinase, and SHPTP2 (Z. Songyang, S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. M. Chou, H. Hanafusa, B. Schaffhausen, and L. C. Cantley, Cell, 72:767-778, 1993).  The authors report here the optimal recognition motifs for SH2 domains from GRB-2, Drk, Csk, Vav, fps/fes, SHC, Syk (carboxy-terminal SH2), 3BP2, and HCP (amino-terminal SH2 domain, also called PTP1C and SHPTP1).  As predicted, SH2 domains from proteins that fall into group I on the basis of a Phe or Tyr at the Î²D5 position (GRB-2, 3BP2, Csk, fps/fes, Syk C-terminal SH2) select phosphopeptides with the general motif phospho-Tyr-hydrophilic (residue)-hydrophilic (residue)-hydrophobic (residue).  The SH2 domains of SHC and HCP (group III proteins with Ile, Leu, or Cys at the Î²D5 position) selected the general motif phospho-Tyr-hydrophobic-Xxx-hydrophobic, also as predicted.  Vav, which has a Thr at the Î²D5 position, selected phospho-Tyr-Met-Glu-Pro as the optimal motif.  Each SH2 domain selected a unique optimal motif distinct from motifs previously detd. for other SH2 domains.  These motifs are used to predict potential sites in signaling proteins for interaction with specific SH2 domain-contg. proteins.  The Syk SH2 domain is predicted to bind to Tyr-hydrophilic-hydrophilic-Leu/Ile motifs like those repeated at 10-residue intervals in T- and B-cell receptor-assocd. proteins.  SHC is predicted to bind to a subgroup of these same motifs.  A structural basis for the assocn. of Csk with Src family members is also suggested from these studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDwa25r4DEDbVg90H21EOLACvtfcHk0liMYM_O8DIesw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXktVenur8%253D&md5=51bfdaf8c43a4b01c39011f79930e85c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FMCB.14.4.2777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.14.4.2777%26sid%3Dliteratum%253Aachs%26aulast%3DSongyang%26aufirst%3DZ.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26aulast%3DMcGlade%26aufirst%3DJ.%26aulast%3DOlivier%26aufirst%3DP.%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DBustelo%26aufirst%3DX.%2BR.%26aulast%3DBarbacid%26aufirst%3DM.%26aulast%3DSabe%26aufirst%3DH.%26aulast%3DHanafusa%26aufirst%3DH.%26aulast%3DYi%26aufirst%3DT.%26atitle%3DSpecific%2520motifs%2520recognized%2520by%2520the%2520SH2%2520domains%2520of%2520Csk%252C%25203BP2%252C%2520fps%252Ffes%252C%2520GRB-2%252C%2520HCP%252C%2520SHC%252C%2520Syk%252C%2520and%2520Vav%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1994%26volume%3D14%26spage%3D2777%26epage%3D2785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Tari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Berestein, G.</span><span> </span><span class="NLM_article-title">GRB2: A pivotal protein in signal transduction</span> <span class="citation_source-journal">Semin. Oncol.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">28</span> <span class="NLM_fpage">142</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1016%2FS0093-7754%2801%2990291-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=11706405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpt1Wnsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=142-147&author=A.+M.+Tariauthor=G.+Lopez-Berestein&title=GRB2%3A+A+pivotal+protein+in+signal+transduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">GRB2: A pivotal protein in signal transduction</span></div><div class="casAuthors">Tari, Ana M.; Lopez-Berestein, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5, Suppl. 16</span>),
    <span class="NLM_cas:pages">142-147</span>CODEN:
                <span class="NLM_cas:coden">SOLGAV</span>;
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">A review.  The growth factor receptor-bound protein-2 (GRB2) is essential for multiple cellular functions.  Inhibition of GRB2 function impairs developmental processes in various organisms and blocks transformation and proliferation of various cell types.  GRB2 is most well known for its ability to link the epidermal growth factor receptor tyrosine kinase to the activation of RAS and its downstream kinases, ERK1,2.  We recently reported that GRB2 does not link the HER2 tyrosine kinase to the activation of ERK1,2 but to another kinase, AKT.  So, different tyrosine kinases may converge on GRB2 for signaling; however, they may not always use GRB2 to effect the same downstream kinases for cellular functions.  It is likely that GRB2 will be found to regulate many more kinases because it plays such a pivotal role in signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_ZWTibbVlXLVg90H21EOLACvtfcHk0liMYM_O8DIesw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpt1Wnsrs%253D&md5=50c9bba406a8f6c14542860a712e2834</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0093-7754%2801%2990291-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0093-7754%252801%252990291-X%26sid%3Dliteratum%253Aachs%26aulast%3DTari%26aufirst%3DA.%2BM.%26aulast%3DLopez-Berestein%26aufirst%3DG.%26atitle%3DGRB2%253A%2520A%2520pivotal%2520protein%2520in%2520signal%2520transduction%26jtitle%3DSemin.%2520Oncol.%26date%3D2001%26volume%3D28%26spage%3D142%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gururaj, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, C. J.</span><span> </span><span class="NLM_article-title">p21-activated kinases in cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">459</span> <span class="NLM_lpage">471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1038%2Fnrc1892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=16723992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvVylt70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=459-471&author=R.+Kumarauthor=A.+E.+Gururajauthor=C.+J.+Barnes&title=p21-activated+kinases+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">p21-activated kinases in cancer</span></div><div class="casAuthors">Kumar, Rakesh; Gururaj, Anupama E.; Barnes, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">459-471</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The pivotal role of kinases in signal transduction and cellular regulation has lent them considerable appeal as pharmacol. targets across a broad spectrum of cancers. p21-activated kinases (Paks) are serine/threonine kinases that function as downstream nodes for various oncogenic signaling pathways.  Paks are well-known regulators of cytoskeletal remodelling and cell motility, but have recently also been shown to promote cell proliferation, regulate apoptosis and accelerate mitotic abnormalities, which results in tumor formation and cell invasiveness.  Alterations in Pak expression have been detected in human tumors, which makes them an attractive new therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEHHgDDNNCdrVg90H21EOLACvtfcHk0liMYM_O8DIesw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvVylt70%253D&md5=d802d2c4dfe3c2fe7846ce643192e46e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrc1892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1892%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DGururaj%26aufirst%3DA.%2BE.%26aulast%3DBarnes%26aufirst%3DC.%2BJ.%26atitle%3Dp21-activated%2520kinases%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D459%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Schlaepfer, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Geer, P.</span><span> </span><span class="NLM_article-title">Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase</span> <span class="citation_source-journal">Nature</span><span class="NLM_year" style="font-weight: bold;">1994</span> <span class="NLM_volume">372</span> <span class="NLM_fpage">786</span> <span class="NLM_lpage">791</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=1994&pages=786-791&author=D.+D.+Schlaepferauthor=S.+K.+Hanksauthor=T.+Hunterauthor=P.+Van+der+Geer&title=Integrin-mediated+signal+transduction+linked+to+Ras+pathway+by+GRB2+binding+to+focal+adhesion+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchlaepfer%26aufirst%3DD.%2BD.%26aulast%3DHanks%26aufirst%3DS.%2BK.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DVan%2Bder%2BGeer%26aufirst%3DP.%26atitle%3DIntegrin-mediated%2520signal%2520transduction%2520linked%2520to%2520Ras%2520pathway%2520by%2520GRB2%2520binding%2520to%2520focal%2520adhesion%2520kinase%26jtitle%3DNature%26date%3D1994%26volume%3D372%26spage%3D786%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Mitra, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikolon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsia, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard-Trifilo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupack, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheresh, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlaepfer, D. D.</span><span> </span><span class="NLM_article-title">Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">25</span> <span class="NLM_fpage">5969</span> <span class="NLM_lpage">5984</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=5969-5984&author=S.+K.+Mitraauthor=D.+Mikolonauthor=J.+E.+Molinaauthor=D.+A.+Hsiaauthor=D.+A.+Hansonauthor=A.+Chiauthor=S.+T.+Limauthor=J.+A.+Bernard-Trifiloauthor=D.+Ilicauthor=D.+G.+Stupackauthor=D.+A.+Chereshauthor=D.+D.+Schlaepfer&title=Intrinsic+FAK+activity+and+Y925+phosphorylation+facilitate+an+angiogenic+switch+in+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMitra%26aufirst%3DS.%2BK.%26aulast%3DMikolon%26aufirst%3DD.%26aulast%3DMolina%26aufirst%3DJ.%2BE.%26aulast%3DHsia%26aufirst%3DD.%2BA.%26aulast%3DHanson%26aufirst%3DD.%2BA.%26aulast%3DChi%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DS.%2BT.%26aulast%3DBernard-Trifilo%26aufirst%3DJ.%2BA.%26aulast%3DIlic%26aufirst%3DD.%26aulast%3DStupack%26aufirst%3DD.%2BG.%26aulast%3DCheresh%26aufirst%3DD.%2BA.%26aulast%3DSchlaepfer%26aufirst%3DD.%2BD.%26atitle%3DIntrinsic%2520FAK%2520activity%2520and%2520Y925%2520phosphorylation%2520facilitate%2520an%2520angiogenic%2520switch%2520in%2520tumors%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26spage%3D5969%26epage%3D5984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">McLean, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carragher, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avizienyte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunton, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frame, M. C.</span><span> </span><span class="NLM_article-title">The role of focal-adhesion kinase in cancerâa new therapeutic opportunity</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">505</span> <span class="NLM_lpage">515</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1038%2Fnrc1647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=16069815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtFOns7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=505-515&author=G.+W.+McLeanauthor=N.+O.+Carragherauthor=E.+Avizienyteauthor=J.+Evansauthor=V.+G.+Bruntonauthor=M.+C.+Frame&title=The+role+of+focal-adhesion+kinase+in+cancer%E2%80%94a+new+therapeutic+opportunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The role of focal-adhesion kinase in cancer - A new therapeutic opportunity</span></div><div class="casAuthors">McLean, Gordon W.; Carragher, Neil O.; Avizienyte, Egle; Evans, Jeff; Brunton, Valerie G.; Frame, Margaret C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">505-515</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  I Focal-adhesion kinase (FAK) is an important mediator of growth-factor signaling, cell proliferation, cell survival and cell migration.  Given that the development of malignancy is often assocd. with perturbations in these processes, it is not surprising that FAK activity is altered in cancer cells.  Mouse models have shown that FAK is involved in tumor formation and progression, and other studies showing that FAK expression is increased in human tumors make FAK a potentially important new therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplqluP90LTaLVg90H21EOLACvtfcHk0ljN5sJ4RwPbZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtFOns7k%253D&md5=805ddeb142a8d73e111cf8211dbcdfa9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrc1647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1647%26sid%3Dliteratum%253Aachs%26aulast%3DMcLean%26aufirst%3DG.%2BW.%26aulast%3DCarragher%26aufirst%3DN.%2BO.%26aulast%3DAvizienyte%26aufirst%3DE.%26aulast%3DEvans%26aufirst%3DJ.%26aulast%3DBrunton%26aufirst%3DV.%2BG.%26aulast%3DFrame%26aufirst%3DM.%2BC.%26atitle%3DThe%2520role%2520of%2520focal-adhesion%2520kinase%2520in%2520cancer%25E2%2580%2594a%2520new%2520therapeutic%2520opportunity%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D505%26epage%3D515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Dharmawardana, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peruzzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giubellino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottaro, D. P.</span><span> </span><span class="NLM_article-title">Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategy</span> <span class="citation_source-journal">Anti-Cancer Drugs</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">17</span> <span class="NLM_fpage">13</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=13-20&author=P.+G.+Dharmawardanaauthor=B.+Peruzziauthor=A.+Giubellinoauthor=J.+Burkeauthor=D.+P.+Bottaro&title=Molecular+targeting+of+growth+factor+receptor-bound+2+%28Grb2%29+as+an+anti-cancer+strategy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDharmawardana%26aufirst%3DP.%2BG.%26aulast%3DPeruzzi%26aufirst%3DB.%26aulast%3DGiubellino%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DJ.%26aulast%3DBottaro%26aufirst%3DD.%2BP.%26atitle%3DMolecular%2520targeting%2520of%2520growth%2520factor%2520receptor-bound%25202%2520%2528Grb2%2529%2520as%2520an%2520anti-cancer%2520strategy%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2006%26volume%3D17%26spage%3D13%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Burke, T. R.</span><span> </span><span class="NLM_article-title">Development of Grb2 SH2 domain signaling antagonists: a potential new class of antiproliferative agents</span> <span class="citation_source-journal">Int. J. Pept. Res. Ther.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">33</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1007%2Fs10989-006-9014-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=19444322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVKlu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=33-48&author=T.+R.+Burke&title=Development+of+Grb2+SH2+domain+signaling+antagonists%3A+a+potential+new+class+of+antiproliferative+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Grb2 SH2 domain signaling antagonists: a potential new class of antiproliferative agents</span></div><div class="casAuthors">Burke, Terrence R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Peptide Research and Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-48</span>CODEN:
                <span class="NLM_cas:coden">IJPRFC</span>;
        ISSN:<span class="NLM_cas:issn">1573-3149</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Aberrant signaling through protein-tyrosine kinase (PTK)-dependent pathways is assocd. with several proliferative diseases.  Accordingly, PTK inhibitors are being developed as new approaches for the treatment of certain cancers.  Growth factor receptor bound protein 2 (Grb2) is an important downstream mediator of PTK signaling that serves obligatory roles in many pathogenic processes.  One of the primary functions of Grb2 is to bind to specific phosphotyrosyl (pTyr)-contg. sequences through its Src homol. 2 (SH2) domain.  Agents that bind to the Grb2 SH2 domain and prevent its normal function could disrupt assocd. PTK signaling and serve as alternatives to kinase-directed inhibitors.  Starting from the x-ray crystal structure of a lead peptide bound to the Grb2 SH2 domain, this review will summarize important contributions to these efforts.  The presentation will be thematically arranged according to the region of peptide modified, proceeding from the N-terminus to the C-terminus, with a special section devoted to aspects of conformational constraint.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpT5-KbxzDDrVg90H21EOLACvtfcHk0lg1ihZpDl_-9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVKlu7o%253D&md5=b7fd41f32b1ba0f9028e34548076c0c1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs10989-006-9014-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10989-006-9014-7%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DDevelopment%2520of%2520Grb2%2520SH2%2520domain%2520signaling%2520antagonists%253A%2520a%2520potential%2520new%2520class%2520of%2520antiproliferative%2520agents%26jtitle%3DInt.%2520J.%2520Pept.%2520Res.%2520Ther.%26date%3D2006%26volume%3D12%26spage%3D33%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Atabey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breckenridge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottaro, D. P.</span><span> </span><span class="NLM_article-title">Potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion and branching morphogenesis by antagonists of Grb2 Src homology 2 domain interactions</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">276</span> <span class="NLM_fpage">14308</span> <span class="NLM_lpage">14314</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=14308-14314&author=N.+Atabeyauthor=Y.+Gaoauthor=Z.+J.+Yaoauthor=D.+Breckenridgeauthor=L.+Soonauthor=J.+V.+Sorianoauthor=T.+R.+Burkeauthor=D.+P.+Bottaro&title=Potent+blockade+of+hepatocyte+growth+factor-stimulated+cell+motility%2C+matrix+invasion+and+branching+morphogenesis+by+antagonists+of+Grb2+Src+homology+2+domain+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtabey%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DZ.%2BJ.%26aulast%3DBreckenridge%26aufirst%3DD.%26aulast%3DSoon%26aufirst%3DL.%26aulast%3DSoriano%26aufirst%3DJ.%2BV.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DBottaro%26aufirst%3DD.%2BP.%26atitle%3DPotent%2520blockade%2520of%2520hepatocyte%2520growth%2520factor-stimulated%2520cell%2520motility%252C%2520matrix%2520invasion%2520and%2520branching%2520morphogenesis%2520by%2520antagonists%2520of%2520Grb2%2520Src%2520homology%25202%2520domain%2520interactions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D14308%26epage%3D14314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Soriano, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underhill, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottaro, D. P.</span><span> </span><span class="NLM_article-title">Inhibition of angiogenesis by growth factor receptor bound protein 2-Src homology 2 domain binding antagonists</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">1289</span> <span class="NLM_lpage">1299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=15486196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVSrs7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1289-1299&author=J.+V.+Sorianoauthor=N.+Liuauthor=Y.+Gaoauthor=Z.+Y.+Yaoauthor=T.+Ishibashiauthor=C.+Underhillauthor=T.+R.+Burkeauthor=D.+P.+Bottaro&title=Inhibition+of+angiogenesis+by+growth+factor+receptor+bound+protein+2-Src+homology+2+domain+binding+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of angiogenesis by growth factor receptor bound protein 2-Src homology 2 domain bound antagonists</span></div><div class="casAuthors">Soriano, Jesus V.; Liu, Ningfei; Gao, Yang; Yao, Zhu-Jun; Ishibashi, Toshio; Underhill, Charles; Burke, Terrence R., Jr.; Bottaro, Donald P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1289-1299</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Growth factor receptor bound protein 2 (Grb2) is an intracellular adaptor protein that participates in the signal transduction cascades of several angiogenic factors, including hepatocyte growth factor, basic fibroblast growth factor, and vascular endothelial growth factor.  We described previously the potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion, and epithelial tubulogenesis by synthetic Grb2-Src homol. 2 (SH2) domain binding antagonists.  Here, we show that these binding antagonists block basic morphogenetic events required for angiogenesis, including hepatocyte growth factor-, vascular endothelial growth factor-, and basic fibroblast growth factor-stimulated endothelial cell proliferation and migration, as well as phorbol 12-myristate 13-acetate-stimulated endothelial cell migration and matrix invasion.  The Grb2-SH2 domain binding antagonists also impair angiogenesis in vitro, as shown by the inhibition of cord formation by macrovascular endothelial cells on Matrigel.  We further show that a representative compd. inhibits angiogenesis in vivo as measured using a chick chorioallantoic membrane assay.  These results suggest that Grb2 is an important mediator of key proangiogenic events, with potential application to pathol. conditions where neovascularization contributes to disease progression.  In particular, the well-characterized role of Grb2 in signaling cell cycle progression together with our present findings suggests that Grb2-SH2 domain binding antagonists have the potential to act as anticancer drugs that target both tumor and vascular cell compartments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXp1fXrsMZY7Vg90H21EOLACvtfcHk0lg1ihZpDl_-9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVSrs7c%253D&md5=6de14544916e3c13f21ef44b520290d4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoriano%26aufirst%3DJ.%2BV.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DZ.%2BY.%26aulast%3DIshibashi%26aufirst%3DT.%26aulast%3DUnderhill%26aufirst%3DC.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DBottaro%26aufirst%3DD.%2BP.%26atitle%3DInhibition%2520of%2520angiogenesis%2520by%2520growth%2520factor%2520receptor%2520bound%2520protein%25202-Src%2520homology%25202%2520domain%2520binding%2520antagonists%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D1289%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Giubellino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasselli, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medepalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepel, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottaro, D. P.</span><span> </span><span class="NLM_article-title">Inhibition of tumor metastasis by a growth factor receptor bound protein 2 Src homology 2 domain-binding antagonist</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">67</span> <span class="NLM_fpage">6012</span> <span class="NLM_lpage">6016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=6012-6016&author=A.+Giubellinoauthor=Y.+Gaoauthor=S.+Leeauthor=M.+J.+Leeauthor=J.+R.+Vasselliauthor=S.+Medepalliauthor=J.+B.+Trepelauthor=T.+R.+Burkeauthor=D.+P.+Bottaro&title=Inhibition+of+tumor+metastasis+by+a+growth+factor+receptor+bound+protein+2+Src+homology+2+domain-binding+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiubellino%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DVasselli%26aufirst%3DJ.%2BR.%26aulast%3DMedepalli%26aufirst%3DS.%26aulast%3DTrepel%26aufirst%3DJ.%2BB.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DBottaro%26aufirst%3DD.%2BP.%26atitle%3DInhibition%2520of%2520tumor%2520metastasis%2520by%2520a%2520growth%2520factor%2520receptor%2520bound%2520protein%25202%2520Src%2520homology%25202%2520domain-binding%2520antagonist%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D6012%26epage%3D6016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Shi, Z. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worthy, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bindu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.</span><span> </span><span class="NLM_article-title">Synthesis of a C-terminally biotinylated macrocyclic peptide mimetic exhibiting high Grb2 SH2 domain-binding affinity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">4200</span> <span class="NLM_lpage">4208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=4200-4208&author=Z.+D.+Shiauthor=H.+Liuauthor=M.+Zhangauthor=K.+M.+Worthyauthor=L.+Binduauthor=D.+Yangauthor=R.+J.+Fisherauthor=T.+R.+Burke&title=Synthesis+of+a+C-terminally+biotinylated+macrocyclic+peptide+mimetic+exhibiting+high+Grb2+SH2+domain-binding+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DZ.%2BD.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DWorthy%26aufirst%3DK.%2BM.%26aulast%3DBindu%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DFisher%26aufirst%3DR.%2BJ.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DSynthesis%2520of%2520a%2520C-terminally%2520biotinylated%2520macrocyclic%2520peptide%2520mimetic%2520exhibiting%2520high%2520Grb2%2520SH2%2520domain-binding%2520affinity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D4200%26epage%3D4208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Sasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsuki, T.</span><span> </span><span class="NLM_article-title">Rational design of Mn-salen catalyst (2): highly enantioselective epoxidation of conjugated cis-olefins</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_year" style="font-weight: bold;">1994</span> <span class="NLM_volume">50</span> <span class="NLM_fpage">11827</span> <span class="NLM_lpage">11838</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=11827-11838&author=H.+Sasakiauthor=R.+Irieauthor=T.+Hamadaauthor=K.+Suzukiauthor=T.+Katsuki&title=Rational+design+of+Mn-salen+catalyst+%282%29%3A+highly+enantioselective+epoxidation+of+conjugated+cis-olefins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DIrie%26aufirst%3DR.%26aulast%3DHamada%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DKatsuki%26aufirst%3DT.%26atitle%3DRational%2520design%2520of%2520Mn-salen%2520catalyst%2520%25282%2529%253A%2520highly%2520enantioselective%2520epoxidation%2520of%2520conjugated%2520cis-olefins%26jtitle%3DTetrahedron%26date%3D1994%26volume%3D50%26spage%3D11827%26epage%3D11838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Cabri, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candiani, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedeschi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santi, R.</span><span> </span><span class="NLM_article-title">1,10-Phenanthroline derivatives: a new ligand class in the Heck reaction. Mechanistic aspects</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_year" style="font-weight: bold;">1993</span> <span class="NLM_volume">58</span> <span class="NLM_fpage">7421</span> <span class="NLM_lpage">7426</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00078a021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=7421-7426&author=W.+Cabriauthor=I.+Candianiauthor=A.+Bedeschiauthor=R.+Santi&title=1%2C10-Phenanthroline+derivatives%3A+a+new+ligand+class+in+the+Heck+reaction.+Mechanistic+aspects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjo00078a021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00078a021%26sid%3Dliteratum%253Aachs%26aulast%3DCabri%26aufirst%3DW.%26aulast%3DCandiani%26aufirst%3DI.%26aulast%3DBedeschi%26aufirst%3DA.%26aulast%3DSanti%26aufirst%3DR.%26atitle%3D1%252C10-Phenanthroline%2520derivatives%253A%2520a%2520new%2520ligand%2520class%2520in%2520the%2520Heck%2520reaction.%2520Mechanistic%2520aspects%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1993%26volume%3D58%26spage%3D7421%26epage%3D7426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.</span><span> </span><span class="NLM_article-title">Stereoselective preparation of <span class="smallcaps smallerCapital">l</span>-4-(2â²-malonyl)phenylalanine suitably protected for Fmoc-based synthesis of potent signal transduction inhibitory ligands</span> <span class="citation_source-journal">Synlett</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_fpage">134</span> <span class="NLM_lpage">136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=134-136&author=Y.+Gaoauthor=T.+R.+Burke&title=Stereoselective+preparation+of+l-4-%282%E2%80%B2-malonyl%29phenylalanine+suitably+protected+for+Fmoc-based+synthesis+of+potent+signal+transduction+inhibitory+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DStereoselective%2520preparation%2520of%2520l-4-%25282%25E2%2580%25B2-malonyl%2529phenylalanine%2520suitably%2520protected%2520for%2520Fmoc-based%2520synthesis%2520of%2520potent%2520signal%2520transduction%2520inhibitory%2520ligands%26jtitle%3DSynlett%26date%3D2000%26spage%3D134%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Mikol, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurini, M. G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hommel, U.</span><span> </span><span class="NLM_article-title">Crystal structure of the SH2 domain from the adaptor protein SHC: a model for peptide binding based on X-ray and NMR data</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">254</span> <span class="NLM_fpage">86</span> <span class="NLM_lpage">95</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=1995&pages=86-95&author=V.+Mikolauthor=G.+Baumannauthor=M.+G.+M.+Zuriniauthor=U.+Hommel&title=Crystal+structure+of+the+SH2+domain+from+the+adaptor+protein+SHC%3A+a+model+for+peptide+binding+based+on+X-ray+and+NMR+data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMikol%26aufirst%3DV.%26aulast%3DBaumann%26aufirst%3DG.%26aulast%3DZurini%26aufirst%3DM.%2BG.%2BM.%26aulast%3DHommel%26aufirst%3DU.%26atitle%3DCrystal%2520structure%2520of%2520the%2520SH2%2520domain%2520from%2520the%2520adaptor%2520protein%2520SHC%253A%2520a%2520model%2520for%2520peptide%2520binding%2520based%2520on%2520X-ray%2520and%2520NMR%2520data%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D254%26spage%3D86%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karki, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Z. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worthy, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bindu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chertov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillette, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maderia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicklaus, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.</span><span> </span><span class="NLM_article-title">Evaluation of macrocyclic Grb2 SH2 domain-binding peptide mimetics prepared by ring-closing metathesis of C-terminal allylglycines with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">2431</span> <span class="NLM_lpage">2438</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=2431-2438&author=S.+Oishiauthor=R.+G.+Karkiauthor=Z.+D.+Shiauthor=K.+M.+Worthyauthor=L.+Binduauthor=O.+Chertovauthor=D.+Espositoauthor=P.+Frankauthor=W.+K.+Gilletteauthor=M.+Maderiaauthor=J.+Hartleyauthor=M.+C.+Nicklausauthor=J.+Barchiauthor=R.+J.+Fisherauthor=T.+R.+Burke&title=Evaluation+of+macrocyclic+Grb2+SH2+domain-binding+peptide+mimetics+prepared+by+ring-closing+metathesis+of+C-terminal+allylglycines+with+an+N-terminal+beta-vinyl-substituted+phosphotyrosyl+mimetic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DKarki%26aufirst%3DR.%2BG.%26aulast%3DShi%26aufirst%3DZ.%2BD.%26aulast%3DWorthy%26aufirst%3DK.%2BM.%26aulast%3DBindu%26aufirst%3DL.%26aulast%3DChertov%26aufirst%3DO.%26aulast%3DEsposito%26aufirst%3DD.%26aulast%3DFrank%26aufirst%3DP.%26aulast%3DGillette%26aufirst%3DW.%2BK.%26aulast%3DMaderia%26aufirst%3DM.%26aulast%3DHartley%26aufirst%3DJ.%26aulast%3DNicklaus%26aufirst%3DM.%2BC.%26aulast%3DBarchi%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DR.%2BJ.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DEvaluation%2520of%2520macrocyclic%2520Grb2%2520SH2%2520domain-binding%2520peptide%2520mimetics%2520prepared%2520by%2520ring-closing%2520metathesis%2520of%2520C-terminal%2520allylglycines%2520with%2520an%2520N-terminal%2520beta-vinyl-substituted%2520phosphotyrosyl%2520mimetic%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D2431%26epage%3D2438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Puto, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pestonjamasp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bokoch, G. M.</span><span> </span><span class="NLM_article-title">p21-activated kinase 1 (PAK1) interacts with the Grb2 adapter protein to couple to growth factor signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">278</span> <span class="NLM_fpage">9388</span> <span class="NLM_lpage">9393</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=9388-9393&author=L.+A.+Putoauthor=K.+Pestonjamaspauthor=C.+C.+Kingauthor=G.+M.+Bokoch&title=p21-activated+kinase+1+%28PAK1%29+interacts+with+the+Grb2+adapter+protein+to+couple+to+growth+factor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuto%26aufirst%3DL.%2BA.%26aulast%3DPestonjamasp%26aufirst%3DK.%26aulast%3DKing%26aufirst%3DC.%2BC.%26aulast%3DBokoch%26aufirst%3DG.%2BM.%26atitle%3Dp21-activated%2520kinase%25201%2520%2528PAK1%2529%2520interacts%2520with%2520the%2520Grb2%2520adapter%2520protein%2520to%2520couple%2520to%2520growth%2520factor%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D9388%26epage%3D9393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Singh, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span> </span><span class="NLM_article-title">Nuclear localization and chromatin targets of p21-activated kinase 1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">280</span> <span class="NLM_fpage">18130</span> <span class="NLM_lpage">18137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=18130-18137&author=R.+R.+Singhauthor=C.+Songauthor=Z.+Yangauthor=R.+Kumar&title=Nuclear+localization+and+chromatin+targets+of+p21-activated+kinase+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DR.%2BR.%26aulast%3DSong%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DKumar%26aufirst%3DR.%26atitle%3DNuclear%2520localization%2520and%2520chromatin%2520targets%2520of%2520p21-activated%2520kinase%25201%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D18130%26epage%3D18137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">OâSullivan, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tangney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrose, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, O. P.</span><span> </span><span class="NLM_article-title">Modulation of p21-activated kinase 1 alters the behavior of renal cell carcinoma</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">121</span> <span class="NLM_fpage">1930</span> <span class="NLM_lpage">1940</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1002%2Fijc.22893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=17621631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSjsL7F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2007&pages=1930-1940&author=G.+C.+O%E2%80%99Sullivanauthor=M.+Tangneyauthor=G.+Caseyauthor=M.+Ambroseauthor=A.+Houstonauthor=O.+P.+Barry&title=Modulation+of+p21-activated+kinase+1+alters+the+behavior+of+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of p21-activated kinase 1 alters the behavior of renal cell carcinoma</span></div><div class="casAuthors">O'Sullivan, Gerald C.; Tangney, Mark; Casey, Garret; Ambrose, Monica; Houston, Aileen; Barry, Orla P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1930-1940</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The p21-activated kinase 1 (Pak1) is a serine/threonine kinase whose activity is regulated by both Rho GTPases and AGC kinase family members.  It plays a role in cytoskeletal remodeling and cell motility as well as cell proliferation, angiogenesis, tumorigenesis and metastasis.  An involvement of Pak1 in renal cell carcinoma (RCC), which remains highly refractory to chemotherapy and radiotherapy, remains to be investigated.  Pak1 expression, phosphorylation and kinase activity were examd. in RCC cell lines and human tissue from normal and renal carcinoma.  We report increased Pak1 expression and constitutive activity in the membrane and nucleus but not the cytoplasm of resected human RCC.  To study a role for Pak1 in RCC, we developed 786-0 clones that expressed either a kinase-active Pak1L83,L86 2 different Pak1 dominant neg. mutants, Pak1R299 and Pak1L83,L86,R299 or Pak1 siRNA.  The expression of Pak1L83,L86 increased 786-0 proliferation, motility and anchorage independent growth, while the dominant neg. mutants and Pak1 siRNA abrogated these effects.  In addn., Pak1L83,L86 conferred resistance to 5-fluorouracil with a 40% Â± 10% increase in cell viability.  Conversely, Pak1L83,L86,R299, Pak1R299 and Pak1 siRNA conferred sensitivity with a 65.2% Â± 5.5%, 69.2% Â± 3.3% and 73.0% Â± 8.4% loss in viability, resp.  Finally, Pak1 plays a role in renal tumor growth in vivo.  Only 33% of mice developed tumors in the Pak1L83,L86,R299 group and no tumors developed from Pak1R299 cell challenge.  Together these findings point to Pak1 as an exciting target for therapy of renal cancer, which remains highly refractory to existing treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8oLNZaOV7gbVg90H21EOLACvtfcHk0lj_d2yLe9luoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSjsL7F&md5=bed92eb73dda915c5a19af8e5b988b1e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fijc.22893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22893%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DG.%2BC.%26aulast%3DTangney%26aufirst%3DM.%26aulast%3DCasey%26aufirst%3DG.%26aulast%3DAmbrose%26aufirst%3DM.%26aulast%3DHouston%26aufirst%3DA.%26aulast%3DBarry%26aufirst%3DO.%2BP.%26atitle%3DModulation%2520of%2520p21-activated%2520kinase%25201%2520alters%2520the%2520behavior%2520of%2520renal%2520cell%2520carcinoma%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D121%26spage%3D1930%26epage%3D1940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Rayala, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span> </span><span class="NLM_article-title">Sliding p21-activated kinase 1 to nucleus impacts tamoxifen sensitivity</span> <span class="citation_source-journal">Biomed. Pharmacother.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">61</span> <span class="NLM_fpage">408</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1016%2Fj.biopha.2007.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=17604944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1Crsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=408-411&author=S.+K.+Rayalaauthor=R.+Kumar&title=Sliding+p21-activated+kinase+1+to+nucleus+impacts+tamoxifen+sensitivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Sliding p21-activated kinase 1 to nucleus impacts tamoxifen sensitivity</span></div><div class="casAuthors">Rayala, Suresh K.; Kumar, Rakesh</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">408-411</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  The anti-estrogen, tamoxifen is the most commonly used treatment for patients with estrogen receptor (ER)-alpha-pos. breast cancer.  Recent data suggest that levels of ER coregulatory proteins as well as extra- and intracellular signaling in response to growth factor stimulation of breast cancer cells play an important role in acquiring resistance to anti-estrogen action.  P21-activated kinase 1 (PAK1), a major target of the small GTPases, growth factors and lipid signaling, regulates cell motility, hormone action, invasiveness, and survival, all of which are required for both tumor development and normal mammary gland development.  Over the years, the PAK1 has been regarded as cytosolic serine-threonine kinase with regulatory function in cytoskeleton reorganization and motility.  However, emerging data now provide evidence of PAK1 function in the nucleus of breast cancer cells.  Elevated PAK1 expression in premenopausal breast cancer patients correlates well with the lack of tamoxifen response despite the presence of ER-alpha expression, and such relationship was even distinctly stronger in breast tumors with nuclear PAK1.  These typical effects of PAK1 are mechanistically linked with the ability of PAK1 to phosphorylate ER-alpha on serine 305, accompanied by secondary activation of serine 118, and such structural modifications may participate in the development of tamoxifen resistance.  These findings suggest that the levels, subcellular localization, and activation status of PAK1 are likely to be important determinants of tamoxifen resistance, and that raising the possibility that tamoxifen resistance might be prevented or reversed by PAK1 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohquj1oKutCLVg90H21EOLACvtfcHk0lj_d2yLe9luoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1Crsbs%253D&md5=df694385f4dd7892d62d23c921b6da97</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2007.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2007.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DRayala%26aufirst%3DS.%2BK.%26aulast%3DKumar%26aufirst%3DR.%26atitle%3DSliding%2520p21-activated%2520kinase%25201%2520to%2520nucleus%2520impacts%2520tamoxifen%2520sensitivity%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2007%26volume%3D61%26spage%3D408%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Machida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, B. J.</span><span> </span><span class="NLM_article-title">The SH2 domain: versatile signaling module and pharmaceutical target</span> <span class="citation_source-journal">Biochim. Biophys. Actaica et Biophysica Acta, Proteins Proteomics</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">1747</span> <span class="NLM_fpage">1</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1016%2Fj.bbapap.2004.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=15680235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFyjsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1747&publication_year=2005&pages=1-25&author=K.+Machidaauthor=B.+J.+Mayer&title=The+SH2+domain%3A+versatile+signaling+module+and+pharmaceutical+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The SH2 domain: versatile signaling module and pharmaceutical target</span></div><div class="casAuthors">Machida, Kazuya; Mayer, Bruce J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1747</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-25</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Src homol. 2 (SH2) domain is the most prevalent protein binding module that recognizes phosphotyrosine.  This â¼100-amino-acid domain is highly conserved structurally despite being found in a wide variety proteins.  Depending on the nature of neighboring protein module(s), such as catalytic domains and other protein binding domains, SH2-contg. proteins play many different roles in cellular protein tyrosine kinase (PTK) signaling pathways.  Accumulating evidence indicates that SH2 domains are highly versatile and exhibit considerable flexibility in how they bind to their ligands.  To illustrate this functional versatility, the authors present 3 specific examples: the SAP, Cbl, and SOCS families of SH2-contg. proteins, which play key roles in immune responses, termination of PTK signaling, and cytokine responses.  In addn., the authors highlight current progress in the development of SH2 domain inhibitors designed to antagonize or modulate PTK signaling in human disease.  Inhibitors of the Grb2 and Src SH2 domains have been extensively studied, with the aim of targeting the Ras pathway and osteoclastic bone resorption, resp.  Despite formidable difficulties in drug design due to the lability and poor cell permeability of neg. charged phosphorylated SH2 ligands, a variety of structure-based strategies have been used to reduce the size, charge, and peptide character of such ligands, leading to the development of high-affinity lead compds. with potent cellular activities.  These studies have also led to new insights into mol. recognition by the SH2 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh0HmXIxaUZbVg90H21EOLACvtfcHk0lj_d2yLe9luoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFyjsQ%253D%253D&md5=9cb0f80f5533c18251abc2cfe54760a9</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2004.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2004.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DMachida%26aufirst%3DK.%26aulast%3DMayer%26aufirst%3DB.%2BJ.%26atitle%3DThe%2520SH2%2520domain%253A%2520versatile%2520signaling%2520module%2520and%2520pharmaceutical%2520target%26jtitle%3DBiochim.%2520Biophys.%2520Actaica%2520et%2520Biophysica%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2005%26volume%3D1747%26spage%3D1%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Songyang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhuri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gish, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haser, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnofsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechleider, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birge, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fajardo, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanafusa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhausen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">SH2 domains recognize specific phosphopeptide sequences</span> <span class="citation_source-journal">Cell</span><span class="NLM_year" style="font-weight: bold;">1993</span> <span class="NLM_volume">72</span> <span class="NLM_fpage">767</span> <span class="NLM_lpage">778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1993&pages=767-778&author=Z.+Songyangauthor=S.+E.+Shoelsonauthor=M.+Chaudhuriauthor=G.+Gishauthor=T.+Pawsonauthor=W.+G.+Haserauthor=F.+Kingauthor=T.+Robertsauthor=S.+Ratnofskyauthor=R.+J.+Lechleiderauthor=B.+G.+Neelauthor=R.+B.+Birgeauthor=J.+E.+Fajardoauthor=M.+M.+Chouauthor=H.+Hanafusaauthor=B.+Schaffhausenauthor=L.+C.+Cantley&title=SH2+domains+recognize+specific+phosphopeptide+sequences"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSongyang%26aufirst%3DZ.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26aulast%3DChaudhuri%26aufirst%3DM.%26aulast%3DGish%26aufirst%3DG.%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DHaser%26aufirst%3DW.%2BG.%26aulast%3DKing%26aufirst%3DF.%26aulast%3DRoberts%26aufirst%3DT.%26aulast%3DRatnofsky%26aufirst%3DS.%26aulast%3DLechleider%26aufirst%3DR.%2BJ.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DBirge%26aufirst%3DR.%2BB.%26aulast%3DFajardo%26aufirst%3DJ.%2BE.%26aulast%3DChou%26aufirst%3DM.%2BM.%26aulast%3DHanafusa%26aufirst%3DH.%26aulast%3DSchaffhausen%26aufirst%3DB.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DSH2%2520domains%2520recognize%2520specific%2520phosphopeptide%2520sequences%26jtitle%3DCell%26date%3D1993%26volume%3D72%26spage%3D767%26epage%3D778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Z.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.</span><span> </span><span class="NLM_article-title">Inhibition of Grb2 SH2 domain binding by non-phosphate- containing ligands 2. 4-(2-Malonyl)phenylalanine as a potent phosphotyrosyl mimetic</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">43</span> <span class="NLM_fpage">911</span> <span class="NLM_lpage">920</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9904248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=911-920&author=Y.+Gaoauthor=J.+Luoauthor=Z.-J.+Yaoauthor=R.+Guoauthor=H.+Zouauthor=J.+Kelleyauthor=J.+H.+Voigtauthor=D.+Yangauthor=T.+R.+Burke&title=Inhibition+of+Grb2+SH2+domain+binding+by+non-phosphate-+containing+ligands+2.+4-%282-Malonyl%29phenylalanine+as+a+potent+phosphotyrosyl+mimetic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm9904248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9904248%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DZ.-J.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DKelley%26aufirst%3DJ.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DInhibition%2520of%2520Grb2%2520SH2%2520domain%2520binding%2520by%2520non-phosphate-%2520containing%2520ligands%25202.%25204-%25282-Malonyl%2529phenylalanine%2520as%2520a%2520potent%2520phosphotyrosyl%2520mimetic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D911%26epage%3D920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Gay, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suarez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caravatti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span> </span><span class="NLM_article-title">Selective Grb2 SH2 inhibitors as anti-Ras therapy</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">83</span> <span class="NLM_fpage">235</span> <span class="NLM_lpage">241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm800523u&amp;key=10.1002%2F%28SICI%291097-0215%2819991008%2983%3A2%3C235%3A%3AAID-IJC15%3E3.0.CO%3B2-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm800523u&amp;key=10471533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm800523u&amp;key=1%3ACAS%3A528%3ADyaK1MXmvVeqsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1999&pages=235-241&author=B.+Gayauthor=S.+Suarezauthor=G.+Caravattiauthor=P.+Furetauthor=T.+Meyerauthor=J.+Schoepfer&title=Selective+Grb2+SH2+inhibitors+as+anti-Ras+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Selective GRB2 SH2 inhibitors as anti-ras therapy</span></div><div class="casAuthors">Gay, Brigitte; Suarez, Stephanie; Caravatti, Giorgio; Furet, Pascal; Meyer, Thomas; Schoepfer, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-241</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Given the key role of Ras in the mitogenic signaling by receptor tyrosine kinases, several targets upstream of Ras may prove to be excellent targets for drugs in the treatment of cancer caused by oncogenic tyrosine kinases.  CGP78850 is a potent competitor of Grb2 SH2-phosphopeptide interactions.  This inhibitor has been obtained by rational drug design and is specific toward the Grb2 SH2 vs. other SH2 domains and the PTB domain of SHC in vitro.  Accordingly, CGP78850 blocks epidermal growth factor receptor (EGFR)-Grb2 and Shc-Grb2 interactions in living cells.  It also inhibits the growth of cells transformed by receptor tyrosine kinases, which transmit a proliferative signal through Grb2 to Ras, but not cells transformed by oncogenic Raf or cells that contain activating Ras mutations.  Moreover, our results demonstrate that, in cells overexpressing receptor tyrosine kinases, such as the EGFR, Grb2 SH2 inhibitors induce expression of the cell cycle inhibitors p21Waf/Cipl/CAP1 and p27Kipl and reverse transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRZqjPZf5qKrVg90H21EOLACvtfcHk0lhoB7fYm9sAiA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvVeqsrw%253D&md5=f309f57f374af52ea1c41b86822fbe60</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819991008%2983%3A2%3C235%3A%3AAID-IJC15%3E3.0.CO%3B2-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819991008%252983%253A2%253C235%253A%253AAID-IJC15%253E3.0.CO%253B2-B%26sid%3Dliteratum%253Aachs%26aulast%3DGay%26aufirst%3DB.%26aulast%3DSuarez%26aufirst%3DS.%26aulast%3DCaravatti%26aufirst%3DG.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DSchoepfer%26aufirst%3DJ.%26atitle%3DSelective%2520Grb2%2520SH2%2520inhibitors%2520as%2520anti-Ras%2520therapy%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1999%26volume%3D83%26spage%3D235%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Z. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worthy, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bindu, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.</span><span> </span><span class="NLM_article-title">Ring-closing metathesis of C-terminal allylglycine residues with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic as an approach to novel Grb2 SH2 domain-binding macrocyles</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">6</span> <span class="NLM_fpage">668</span> <span class="NLM_lpage">674</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=668-674&author=S.+Oishiauthor=Z.+D.+Shiauthor=K.+M.+Worthyauthor=L.+K.+Binduauthor=R.+J.+Fisherauthor=T.+R.+Burke&title=Ring-closing+metathesis+of+C-terminal+allylglycine+residues+with+an+N-terminal+beta-vinyl-substituted+phosphotyrosyl+mimetic+as+an+approach+to+novel+Grb2+SH2+domain-binding+macrocyles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DShi%26aufirst%3DZ.%2BD.%26aulast%3DWorthy%26aufirst%3DK.%2BM.%26aulast%3DBindu%26aufirst%3DL.%2BK.%26aulast%3DFisher%26aufirst%3DR.%2BJ.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DRing-closing%2520metathesis%2520of%2520C-terminal%2520allylglycine%2520residues%2520with%2520an%2520N-terminal%2520beta-vinyl-substituted%2520phosphotyrosyl%2520mimetic%2520as%2520an%2520approach%2520to%2520novel%2520Grb2%2520SH2%2520domain-binding%2520macrocyles%26jtitle%3DChemBioChem%26date%3D2005%26volume%3D6%26spage%3D668%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm800523u&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-23%3Barticle%3Aarticle%3A10.1021%2Fjm800523u" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm800523u" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                901KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677ad68d09943cfa","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
